Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1999 Nov 30;161(11):S1–S62.

Canadian asthma consensus report, 1999

L P Boulet 1, A Becker 1, D Bérubé 1, R Beveridge 1, P Ernst 1
PMCID: PMC1230847  PMID: 10906907

Abstract

OBJECTIVES: To provide physicians with current guidelines for the diagnosis and optimal management of asthma in children and adults, including pregnant women and the elderly, in office, emergency department, hospital and clinic settings. OPTIONS: The consensus group considered the roles of education, avoidance of provocative environmental and other factors, diverse pharmacotherapies, delivery devices and emergency and in-hospital management of asthma. OUTCOMES: Provision of the best control of asthma by confirmation of the diagnosis using objective measures, rapid achievement and maintenance of control and regular follow-up. EVIDENCE: The key diagnostic and therapeutic recommendations are based on the 1995 Canadian guidelines and a critical review of the literature by small groups before a full meeting of the consensus group. Recommendations are graded according to 5 levels of evidence. Differences of opinion were resolved by consensus following discussion. VALUES: Respirologists, immunoallergists, pediatricians and emergency and family physicians gave prime consideration to the achievement and maintenance of optimal control of asthma through avoidance of environmental inciters, education of patients and the lowest effective regime of pharmacotherapy to reduce morbidity and mortality. BENEFITS, HARMS AND COSTS: Adherence to the guidelines should be accompanied by significant reduction in patients' symptoms, reduced morbidity and mortality, fewer emergency and hospital admissions, fewer adverse side-effects from medications, better quality of life for patients and reduced costs. RECOMMENDATIONS: Recommendations are included in each section of the report. In summary, after a diagnosis of asthma is made based on clinical evaluation, including demonstration of variable airflow obstruction, and contributing factors are identified, a treatment plan is established to obtain and maintain optimal asthma control. The main components of treatment are patient education, environmental control, pharmacotherapy tailored to the individual and regular follow-up. VALIDATION: The recommendations were distributed to the members of the Canadian Thoracic Society Asthma and Standards Committees, as well as members of the board of the Canadian Thoracic Society. In addition, collaborating groups representing the Canadian Association of Emergency Physicians, the Canadian College of Family Physicians, the Canadian Paediatric Society and the Canadian Society of Allergy and Immunology were asked to validate the recommendations. The recommendations were discussed at regional meetings throughout Canada. They were also compared with the recommendations of other similar groups in other countries. DISSEMINATION AND IMPLEMENTATION: An implementation committee has established a strategy for disseminating these guidelines to physicians, other health professionals and patients and for developing tools and means that will help integrate the recommendations into current asthma care. The plan is outlined in this report.

Full Text

The Full Text of this article is available as a PDF (793.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abramson M. J., Puy R. M., Weiner J. M. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. Am J Respir Crit Care Med. 1995 Apr;151(4):969–974. doi: 10.1164/ajrccm.151.4.7697274. [DOI] [PubMed] [Google Scholar]
  2. Adelroth E., Hargreave F. E., Ramsdale E. H. Do physicians need objective measurements to diagnose asthma? Am Rev Respir Dis. 1986 Oct;134(4):704–707. doi: 10.1164/arrd.1986.134.4.704. [DOI] [PubMed] [Google Scholar]
  3. Adelroth E., Inman M. D., Summers E., Pace D., Modi M., O'Byrne P. M. Prolonged protection against exercise-induced bronchoconstriction by the leukotriene D4-receptor antagonist cinalukast. J Allergy Clin Immunol. 1997 Feb;99(2):210–215. doi: 10.1016/s0091-6749(97)70098-8. [DOI] [PubMed] [Google Scholar]
  4. Adkinson N. F., Jr, Eggleston P. A., Eney D., Goldstein E. O., Schuberth K. C., Bacon J. R., Hamilton R. G., Weiss M. E., Arshad H., Meinert C. L. A controlled trial of immunotherapy for asthma in allergic children. N Engl J Med. 1997 Jan 30;336(5):324–331. doi: 10.1056/NEJM199701303360502. [DOI] [PubMed] [Google Scholar]
  5. Agertoft L., Pedersen S. Importance of the inhalation device on the effect of budesonide. Arch Dis Child. 1993 Jul;69(1):130–133. doi: 10.1136/adc.69.1.130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Alexander A. G., Barnes N. C., Kay A. B., Corrigan C. J. Clinical response to cyclosporin in chronic severe asthma is associated with reduction in serum soluble interleukin-2 receptor concentrations. Eur Respir J. 1995 Apr;8(4):574–578. [PubMed] [Google Scholar]
  7. Alexander A. G., Barnes N. C., Kay A. B. Trial of cyclosporin in corticosteroid-dependent chronic severe asthma. Lancet. 1992 Feb 8;339(8789):324–328. doi: 10.1016/0140-6736(92)91646-p. [DOI] [PubMed] [Google Scholar]
  8. Alexander S., Dodds L., Armson B. A. Perinatal outcomes in women with asthma during pregnancy. Obstet Gynecol. 1998 Sep;92(3):435–440. doi: 10.1016/s0029-7844(98)00191-4. [DOI] [PubMed] [Google Scholar]
  9. Allen D. B., Bronsky E. A., LaForce C. F., Nathan R. A., Tinkelman D. G., Vandewalker M. L., Konig P. Growth in asthmatic children treated with fluticasone propionate. Fluticasone Propionate Asthma Study Group. J Pediatr. 1998 Mar;132(3 Pt 1):472–477. doi: 10.1016/s0022-3476(98)70023-x. [DOI] [PubMed] [Google Scholar]
  10. Allen R. M., Jones M. P., Oldenburg B. Randomised trial of an asthma self-management programme for adults. Thorax. 1995 Jul;50(7):731–738. doi: 10.1136/thx.50.7.731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Allen S. C., Prior A. What determines whether an elderly patient can use a metered dose inhaler correctly? Br J Dis Chest. 1986 Jan;80(1):45–49. doi: 10.1016/0007-0971(86)90008-2. [DOI] [PubMed] [Google Scholar]
  12. Altraja A., Laitinen A., Meriste S., Marran S., Märtson T., Sillastu H., Laitinen L. A. Effect of regular nedocromil sodium or albuterol on bronchial inflammation in chronic asthma. J Allergy Clin Immunol. 1996 Nov;98(5 Pt 2):S58–S66. [PubMed] [Google Scholar]
  13. Alvarez J., Surs W., Leung D. Y., Iklé D., Gelfand E. W., Szefler S. J. Steroid-resistant asthma: immunologic and pharmacologic features. J Allergy Clin Immunol. 1992 Mar;89(3):714–721. doi: 10.1016/0091-6749(92)90379-g. [DOI] [PubMed] [Google Scholar]
  14. Amirav I., Goren A., Pawlowski N. A. What do pediatricians in training know about the correct use of inhalers and spacer devices? J Allergy Clin Immunol. 1994 Oct;94(4):669–675. doi: 10.1016/0091-6749(94)90173-2. [DOI] [PubMed] [Google Scholar]
  15. Ariano R., Panzani R. C., Augeri G. Late onset asthma clinical and immunological data: importance of allergy. J Investig Allergol Clin Immunol. 1998 Jan-Feb;8(1):35–41. [PubMed] [Google Scholar]
  16. Aris R. M., Christian D., Hearne P. Q., Kerr K., Finkbeiner W. E., Balmes J. R. Ozone-induced airway inflammation in human subjects as determined by airway lavage and biopsy. Am Rev Respir Dis. 1993 Nov;148(5):1363–1372. doi: 10.1164/ajrccm/148.5.1363. [DOI] [PubMed] [Google Scholar]
  17. Arkinstall W. W., Atkins M. E., Harrison D., Stewart J. H. Once-daily sustained-release theophylline reduces diurnal variation in spirometry and symptomatology in adult asthmatics. Am Rev Respir Dis. 1987 Feb;135(2):316–321. doi: 10.1164/arrd.1987.135.2.316. [DOI] [PubMed] [Google Scholar]
  18. Avol E. L., Linn W. S., Whynot J. D., Anderson K. R., Shamoo D. A., Valencia L. M., Little D. E., Hackney J. D. Respiratory dose-response study of normal and asthmatic volunteers exposed to sulfuric acid aerosol in the sub-micrometer size range. Toxicol Ind Health. 1988 Jun;4(2):173–184. doi: 10.1177/074823378800400203. [DOI] [PubMed] [Google Scholar]
  19. BROCKLEHURST W. E. The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock. J Physiol. 1960 Jun;151:416–435. doi: 10.1113/jphysiol.1960.sp006449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Bailey W. C., Richards J. M., Jr, Brooks C. M., Soong S. J., Windsor R. A., Manzella B. A. A randomized trial to improve self-management practices of adults with asthma. Arch Intern Med. 1990 Aug;150(8):1664–1668. [PubMed] [Google Scholar]
  21. Ball B. A., Folinsbee L. J., Peden D. B., Kehrl H. R. Allergen bronchoprovocation of patients with mild allergic asthma after ozone exposure. J Allergy Clin Immunol. 1996 Sep;98(3):563–572. doi: 10.1016/s0091-6749(96)70090-8. [DOI] [PubMed] [Google Scholar]
  22. Banerjee D. K., Lee G. S., Malik S. K., Daly S. Underdiagnosis of asthma in the elderly. Br J Dis Chest. 1987 Jan;81(1):23–29. doi: 10.1016/0007-0971(87)90104-5. [DOI] [PubMed] [Google Scholar]
  23. Banner A. S., Shah R. S., Addington W. W. Rapid prediction of need for hospitalization in acute asthma. JAMA. 1976 Mar 29;235(13):1337–1338. [PubMed] [Google Scholar]
  24. Barnes P. J., Greening A. P., Crompton G. K. Glucocorticoid resistance in asthma. Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 2):S125–S140. doi: 10.1164/ajrccm/152.6_Pt_2.S125. [DOI] [PubMed] [Google Scholar]
  25. Barnes P. J., Greening A. P., Neville L., Timmers J., Poole G. W. Single-dose slow-release aminophylline at night prevents nocturnal asthma. Lancet. 1982 Feb 6;1(8267):299–301. doi: 10.1016/s0140-6736(82)91566-5. [DOI] [PubMed] [Google Scholar]
  26. Barnes P. J. Inhaled glucocorticoids for asthma. N Engl J Med. 1995 Mar 30;332(13):868–875. doi: 10.1056/NEJM199503303321307. [DOI] [PubMed] [Google Scholar]
  27. Barnes P. J. Is there a role for immunotherapy in the treatment of asthma? No. Am J Respir Crit Care Med. 1996 Nov;154(5):1227–1228. doi: 10.1164/ajrccm.154.5.8912730. [DOI] [PubMed] [Google Scholar]
  28. Barnes P. J., Pauwels R. A. Theophylline in the management of asthma: time for reappraisal? Eur Respir J. 1994 Mar;7(3):579–591. doi: 10.1183/09031936.94.07030579. [DOI] [PubMed] [Google Scholar]
  29. Barnes P. J., Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992. Am Rev Respir Dis. 1993 Oct;148(4 Pt 2):S1–26. doi: 10.1164/ajrccm/148.4_Pt_2.S1. [DOI] [PubMed] [Google Scholar]
  30. Barry P. W., O'Callaghan C. The effect of delay, multiple actuations and spacer static charge on the in vitro delivery of budesonide from the Nebuhaler. Br J Clin Pharmacol. 1995 Jul;40(1):76–78. doi: 10.1111/j.1365-2125.1995.tb04538.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Bartter T., Pratter M. R. Asthma: better outcome at lower cost? The role of the expert in the care system. Chest. 1996 Dec;110(6):1589–1596. doi: 10.1378/chest.110.6.1589. [DOI] [PubMed] [Google Scholar]
  32. Bascom R., Naclerio R. M., Fitzgerald T. K., Kagey-Sobotka A., Proud D. Effect of ozone inhalation on the response to nasal challenge with antigen of allergic subjects. Am Rev Respir Dis. 1990 Sep;142(3):594–601. doi: 10.1164/ajrccm/142.3.594. [DOI] [PubMed] [Google Scholar]
  33. Bates D. V., Baker-Anderson M., Sizto R. Asthma attack periodicity: a study of hospital emergency visits in Vancouver. Environ Res. 1990 Feb;51(1):51–70. doi: 10.1016/s0013-9351(05)80182-3. [DOI] [PubMed] [Google Scholar]
  34. Bates D. V., Sizto R. Air pollution and hospital admissions in Southern Ontario: the acid summer haze effect. Environ Res. 1987 Aug;43(2):317–331. doi: 10.1016/s0013-9351(87)80032-4. [DOI] [PubMed] [Google Scholar]
  35. Bauer B. A., Reed C. E., Yunginger J. W., Wollan P. C., Silverstein M. D. Incidence and outcomes of asthma in the elderly. A population-based study in Rochester, Minnesota. Chest. 1997 Feb;111(2):303–310. doi: 10.1378/chest.111.2.303. [DOI] [PubMed] [Google Scholar]
  36. Baumann U. A., Haerdi E., Keller R. Relations between clinical signs and lung function in bronchial asthma: how is acute bronchial obstruction reflected in dyspnoea and wheezing? Respiration. 1986;50(4):294–300. doi: 10.1159/000194941. [DOI] [PubMed] [Google Scholar]
  37. Beasley R., Cushley M., Holgate S. T. A self management plan in the treatment of adult asthma. Thorax. 1989 Mar;44(3):200–204. doi: 10.1136/thx.44.3.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Beasley R., Cushley M., Holgate S. T. A self management plan in the treatment of adult asthma. Thorax. 1989 Mar;44(3):200–204. doi: 10.1136/thx.44.3.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Becker A. B., Nelson N. A., Simons F. E. Inhaled salbutamol (albuterol) vs injected epinephrine in the treatment of acute asthma in children. J Pediatr. 1983 Mar;102(3):465–469. doi: 10.1016/s0022-3476(83)80679-9. [DOI] [PubMed] [Google Scholar]
  40. Becker A. B., Simons F. E., Benoit T. C., Gillespie C. A. Terbutaline by metered-dose inhaler: conventional inhaler versus tube spacer for children with asthma. Ann Allergy. 1985 Nov;55(5):724–728. [PubMed] [Google Scholar]
  41. Bel E. H., Timmers M. C., Hermans J., Dijkman J. H., Sterk P. J. The long-term effects of nedocromil sodium and beclomethasone dipropionate on bronchial responsiveness to methacholine in nonatopic asthmatic subjects. Am Rev Respir Dis. 1990 Jan;141(1):21–28. doi: 10.1164/ajrccm/141.1.21. [DOI] [PubMed] [Google Scholar]
  42. Bellia V., Cuttitta G., Cibella F., Vignola A. M., Crescimanno G., D'Accardi P., Catalano F., Bonsignore G. Effect of ageing on peak expiratory flow variability and nocturnal exacerbations in bronchial asthma. Eur Respir J. 1997 Aug;10(8):1803–1808. doi: 10.1183/09031936.97.10081803. [DOI] [PubMed] [Google Scholar]
  43. Ben-Noun L. Acute asthma associated with sustained-release verapamil. Ann Pharmacother. 1997 May;31(5):593–595. doi: 10.1177/106002809703100514. [DOI] [PubMed] [Google Scholar]
  44. Benito Fernández J., Mintegui Raso S., Sánchez Echaniz J., Montejo Fernández M., Soto Pedre E. Utilidad de la saturación de oxígeno y del pico máximo de flujo espiratorio en el manejo de las crisis asmáticas. An Esp Pediatr. 1996 Oct;45(4):361–364. [PubMed] [Google Scholar]
  45. Bergmann K. C., Bauer C. P., Overlack A. A placebo-controlled, blind comparison of nedocromil sodium and beclomethasone dipropionate in bronchial asthma. Curr Med Res Opin. 1989;11(8):533–542. doi: 10.1185/03007998909110465. [DOI] [PubMed] [Google Scholar]
  46. Berlow B. A., Liebhaber M. I., Dyer Z., Spiegel T. M. The effect of dapsone in steroid-dependent asthma. J Allergy Clin Immunol. 1991 Mar;87(3):710–715. doi: 10.1016/0091-6749(91)90393-3. [DOI] [PubMed] [Google Scholar]
  47. Bernard-Bonnin A. C., Stachenko S., Bonin D., Charette C., Rousseau E. Self-management teaching programs and morbidity of pediatric asthma: a meta-analysis. J Allergy Clin Immunol. 1995 Jan;95(1 Pt 1):34–41. doi: 10.1016/s0091-6749(95)70150-8. [DOI] [PubMed] [Google Scholar]
  48. Bernstein D. I., Bernstein I. L., Bodenheimer S. S., Pietrusko R. G. An open study of auranofin in the treatment of steroid-dependent asthma. J Allergy Clin Immunol. 1988 Jan;81(1):6–16. doi: 10.1016/0091-6749(88)90213-8. [DOI] [PubMed] [Google Scholar]
  49. Bernstein I. L., Bernstein D. I., Dubb J. W., Faiferman I., Wallin B. A placebo-controlled multicenter study of auranofin in the treatment of patients with corticosteroid-dependent asthma. Auranofin Multicenter Drug Trial. J Allergy Clin Immunol. 1996 Aug;98(2):317–324. doi: 10.1016/s0091-6749(96)70156-2. [DOI] [PubMed] [Google Scholar]
  50. Beveridge R. C., Grunfeld A. F., Hodder R. V., Verbeek P. R. Guidelines for the emergency management of asthma in adults. CAEP/CTS Asthma Advisory Committee. Canadian Association of Emergency Physicians and the Canadian Thoracic Society. CMAJ. 1996 Jul 1;155(1):25–37. [PMC free article] [PubMed] [Google Scholar]
  51. Beveridge R. C., Grunfeld A. F., Hodder R. V., Verbeek P. R. Guidelines for the emergency management of asthma in adults. CAEP/CTS Asthma Advisory Committee. Canadian Association of Emergency Physicians and the Canadian Thoracic Society. CMAJ. 1996 Jul 1;155(1):25–37. [PMC free article] [PubMed] [Google Scholar]
  52. Beveridge R. C., Grunfeld A. F., Hodder R. V., Verbeek P. R. Guidelines for the emergency management of asthma in adults. CAEP/CTS Asthma Advisory Committee. Canadian Association of Emergency Physicians and the Canadian Thoracic Society. CMAJ. 1996 Jul 1;155(1):25–37. [PMC free article] [PubMed] [Google Scholar]
  53. Beveridge R. C., Grunfeld A. F., Hodder R. V., Verbeek P. R. Guidelines for the emergency management of asthma in adults. CAEP/CTS Asthma Advisory Committee. Canadian Association of Emergency Physicians and the Canadian Thoracic Society. CMAJ. 1996 Jul 1;155(1):25–37. [PMC free article] [PubMed] [Google Scholar]
  54. Bhagat R., Kalra S., Swystun V. A., Cockcroft D. W. Rapid onset of tolerance to the bronchoprotective effect of salmeterol. Chest. 1995 Nov;108(5):1235–1239. doi: 10.1378/chest.108.5.1235. [DOI] [PubMed] [Google Scholar]
  55. Bhagat R., Swystun V. A., Cockcroft D. W. Salbutamol-induced increased airway responsiveness to allergen and reduced protection versus methacholine: dose response. J Allergy Clin Immunol. 1996 Jan;97(1 Pt 1):47–52. doi: 10.1016/s0091-6749(96)70282-8. [DOI] [PubMed] [Google Scholar]
  56. Bierman M. I., Brown M., Muren O., Keenan R. L., Glauser F. L. Prolonged isoflurane anesthesia in status asthmaticus. Crit Care Med. 1986 Sep;14(9):832–833. doi: 10.1097/00003246-198609000-00017. [DOI] [PubMed] [Google Scholar]
  57. Bisgaard H. A metal aerosol holding chamber devised for young children with asthma. Eur Respir J. 1995 May;8(5):856–860. [PubMed] [Google Scholar]
  58. Bisgaard H., Anhøj J., Klug B., Berg E. A non-electrostatic spacer for aerosol delivery. Arch Dis Child. 1995 Sep;73(3):226–230. doi: 10.1136/adc.73.3.226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Bisgaard H. Automatic actuation of a dry powder inhaler into a nonelectrostatic spacer. Am J Respir Crit Care Med. 1998 Feb;157(2):518–521. doi: 10.1164/ajrccm.157.2.9705025. [DOI] [PubMed] [Google Scholar]
  60. Blais L., Ernst P., Boivin J. F., Suissa S. Inhaled corticosteroids and the prevention of readmission to hospital for asthma. Am J Respir Crit Care Med. 1998 Jul;158(1):126–132. doi: 10.1164/ajrccm.158.1.9707107. [DOI] [PubMed] [Google Scholar]
  61. Bloomfield P., Carmichael J., Petrie G. R., Jewell N. P., Crompton G. K. Comparison of salbutamol given intravenously and by intermittent positive-pressure breathing in life-threatening asthma. Br Med J. 1979 Mar 31;1(6167):848–850. doi: 10.1136/bmj.1.6167.848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Bolton M. B., Tilley B. C., Kuder J., Reeves T., Schultz L. R. The cost and effectiveness of an education program for adults who have asthma. J Gen Intern Med. 1991 Sep-Oct;6(5):401–407. doi: 10.1007/BF02598160. [DOI] [PubMed] [Google Scholar]
  63. Bone M. F., Kubik M. M., Keaney N. P., Summers G. D., Connolly C. K., Burge P. S., Dent R. G., Allan G. W. Nedocromil sodium in adults with asthma dependent on inhaled corticosteroids: a double blind, placebo controlled study. Thorax. 1989 Aug;44(8):654–659. doi: 10.1136/thx.44.8.654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Borduas F., Carrier R., Drouin D., Deslauriers D., Tremblay G. An interactive workshop: An effective means of integrating the Canadian Cardiovascular Society clinical practice guidelines on congestive heart failure into Canadian family physicians' practice. Can J Cardiol. 1998 Jul;14(7):911–916. [PubMed] [Google Scholar]
  65. Boulet L. P., Cartier A., Cockcroft D. W., Gruber J. M., Laberge F., MacDonald G. F., Malo J. L., Mazza J. A., Moote W. D., Sandham J. D. Tolerance to reduction of oral steroid dosage in severely asthmatic patients receiving nedocromil sodium. Respir Med. 1990 Jul;84(4):317–323. doi: 10.1016/s0954-6111(08)80060-1. [DOI] [PubMed] [Google Scholar]
  66. Bousquet J., Aubert B., Bons J. Comparison of salmeterol with disodium cromoglycate in the treatment of adult asthma. Ann Allergy Asthma Immunol. 1996 Feb;76(2):189–194. doi: 10.1016/s1081-1206(10)63421-7. [DOI] [PubMed] [Google Scholar]
  67. Bousquet J., Hejjaoui A., Clauzel A. M., Guérin B., Dhivert H., Skassa-Brociek W., Michel F. B. Specific immunotherapy with a standardized Dermatophagoides pteronyssinus extract. II. Prediction of efficacy of immunotherapy. J Allergy Clin Immunol. 1988 Dec;82(6):971–977. doi: 10.1016/0091-6749(88)90133-9. [DOI] [PubMed] [Google Scholar]
  68. Bowton D. L., Goldsmith W. M., Haponik E. F. Substitution of metered-dose inhalers for hand-held nebulizers. Success and cost savings in a large, acute-care hospital. Chest. 1992 Feb;101(2):305–308. doi: 10.1378/chest.101.2.305. [DOI] [PubMed] [Google Scholar]
  69. Braman S. S., Kaemmerlen J. T., Davis S. M. Asthma in the elderly. A comparison between patients with recently acquired and long-standing disease. Am Rev Respir Dis. 1991 Feb;143(2):336–340. doi: 10.1164/ajrccm/143.2.336. [DOI] [PubMed] [Google Scholar]
  70. Breitigan J. M. Counseling about chlorofluorocarbon-free inhalers. Am J Health Syst Pharm. 1998 Feb 1;55(3):226–227. doi: 10.1093/ajhp/55.3.226. [DOI] [PubMed] [Google Scholar]
  71. Brenner M., Berkowitz R., Marshall N., Strunk R. C. Need for theophylline in severe steroid-requiring asthmatics. Clin Allergy. 1988 Mar;18(2):143–150. doi: 10.1111/j.1365-2222.1988.tb02853.x. [DOI] [PubMed] [Google Scholar]
  72. Britton J., Tattersfield A. Comparison of cumulative and non-cumulative techniques to measure dose-response curves for beta agonists in patients with asthma. Thorax. 1984 Aug;39(8):597–599. doi: 10.1136/thx.39.8.597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Brogden R. N., Sorkin E. M. Nedocromil sodium. An updated review of its pharmacological properties and therapeutic efficacy in asthma. Drugs. 1993 May;45(5):693–715. doi: 10.2165/00003495-199345050-00007. [DOI] [PubMed] [Google Scholar]
  74. Browne G. J., Penna A. S., Phung X., Soo M. Randomised trial of intravenous salbutamol in early management of acute severe asthma in children. Lancet. 1997 Feb 1;349(9048):301–305. doi: 10.1016/S0140-6736(96)06358-1. [DOI] [PubMed] [Google Scholar]
  75. Bryant D. H., Burns M. W. Skin-prick test reactions to inhalant allergens in asthmatic patients. Med J Aust. 1976 Jun 12;1(24):918–924. [PubMed] [Google Scholar]
  76. Bryant D. H. Nebulized ipratropium bromide in the treatment of acute asthma. Chest. 1985 Jul;88(1):24–29. doi: 10.1378/chest.88.1.24. [DOI] [PubMed] [Google Scholar]
  77. Bucknall C. E., Robertson C., Moran F., Stevenson R. D. Management of asthma in hospital: a prospective audit. Br Med J (Clin Res Ed) 1988 Jun 11;296(6637):1637–1639. doi: 10.1136/bmj.296.6637.1637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Burdon J. G., Juniper E. F., Killian K. J., Hargreave F. E., Campbell E. J. The perception of breathlessness in asthma. Am Rev Respir Dis. 1982 Nov;126(5):825–828. doi: 10.1164/arrd.1982.126.5.825. [DOI] [PubMed] [Google Scholar]
  79. Burge P. S. Single and serial measurements of lung function in the diagnosis of occupational asthma. Eur J Respir Dis Suppl. 1982;123:47–59. [PubMed] [Google Scholar]
  80. Burki N. K. The effects of the combination of inhaled ipratropium and oral theophylline in asthma. Chest. 1997 Jun;111(6):1509–1513. doi: 10.1378/chest.111.6.1509. [DOI] [PubMed] [Google Scholar]
  81. Burr M. L., Charles T. J., Roy K., Seaton A. Asthma in the elderly: an epidemiological survey. Br Med J. 1979 Apr 21;1(6170):1041–1044. doi: 10.1136/bmj.1.6170.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Burr M. L., Dean B. V., Merrett T. G., Neale E., St Leger A. S., Verrier-Jones E. R. Effects of anti-mite measures on children with mite-sensitive asthma: a controlled trial. Thorax. 1980 Jul;35(7):506–512. doi: 10.1136/thx.35.7.506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Burr M. L., Merrett T. G., Dunstan F. D., Maguire M. J. The development of allergy in high-risk children. Clin Exp Allergy. 1997 Nov;27(11):1247–1253. [PubMed] [Google Scholar]
  84. Burrows B., Barbee R. A., Cline M. G., Knudson R. J., Lebowitz M. D. Characteristics of asthma among elderly adults in a sample of the general population. Chest. 1991 Oct;100(4):935–942. doi: 10.1378/chest.100.4.935. [DOI] [PubMed] [Google Scholar]
  85. Burrows B., Martinez F. D., Halonen M., Barbee R. A., Cline M. G. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med. 1989 Feb 2;320(5):271–277. doi: 10.1056/NEJM198902023200502. [DOI] [PubMed] [Google Scholar]
  86. Calderón E., Coffey R. G., Lockey R. F. Methotrexate in bronchial asthma. J Allergy Clin Immunol. 1991 Aug;88(2):274–276. doi: 10.1016/0091-6749(91)90339-p. [DOI] [PubMed] [Google Scholar]
  87. Call R. S., Smith T. F., Morris E., Chapman M. D., Platts-Mills T. A. Risk factors for asthma in inner city children. J Pediatr. 1992 Dec;121(6):862–866. doi: 10.1016/s0022-3476(05)80329-4. [DOI] [PubMed] [Google Scholar]
  88. Campbell M. J., Cogman G. R., Holgate S. T., Johnston S. L. Age specific trends in asthma mortality in England and Wales, 1983-95: results of an observational study. BMJ. 1997 May 17;314(7092):1439–1441. doi: 10.1136/bmj.314.7092.1439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Canny G. J., Reisman J., Levison H. Does ketotifen have a steroid-sparing effect in childhood asthma? Eur Respir J. 1997 Jan;10(1):65–70. doi: 10.1183/09031936.97.10010065. [DOI] [PubMed] [Google Scholar]
  90. Cantani A., Arcese G., Lucenti P., Gagliesi D., Bartolucci M. A three-year prospective study of specific immunotherapy to inhalant allergens: evidence of safety and efficacy in 300 children with allergic asthma. J Investig Allergol Clin Immunol. 1997 Mar-Apr;7(2):90–97. [PubMed] [Google Scholar]
  91. Carlsen K. H., Røksund O., Olsholt K., Njå F., Leegaard J., Bratten G. Overnight protection by inhaled salmeterol on exercise-induced asthma in children. Eur Respir J. 1995 Nov;8(11):1852–1855. doi: 10.1183/09031936.95.08111852. [DOI] [PubMed] [Google Scholar]
  92. Carmichael J., Paterson I. C., Diaz P., Crompton G. K., Kay A. B., Grant I. W. Corticosteroid resistance in chronic asthma. Br Med J (Clin Res Ed) 1981 May 2;282(6274):1419–1422. doi: 10.1136/bmj.282.6274.1419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Carter G. W., Young P. R., Albert D. H., Bouska J., Dyer R., Bell R. L., Summers J. B., Brooks D. W. 5-lipoxygenase inhibitory activity of zileuton. J Pharmacol Exp Ther. 1991 Mar;256(3):929–937. [PubMed] [Google Scholar]
  94. Cartier A., Bernstein I. L., Burge P. S., Cohn J. R., Fabbri L. M., Hargreave F. E., Malo J. L., McKay R. T., Salvaggio J. E. Guidelines for bronchoprovocation on the investigation of occupational asthma. Report of the Subcommittee on Bronchoprovocation for Occupational Asthma. J Allergy Clin Immunol. 1989 Nov;84(5 Pt 2):823–829. doi: 10.1016/0091-6749(89)90346-1. [DOI] [PubMed] [Google Scholar]
  95. Castle W., Fuller R., Hall J., Palmer J. Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. BMJ. 1993 Apr 17;306(6884):1034–1037. doi: 10.1136/bmj.306.6884.1034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Chan-Yeung M. Assessment of asthma in the workplace. ACCP consensus statement. American College of Chest Physicians. Chest. 1995 Oct;108(4):1084–1117. doi: 10.1378/chest.108.4.1084. [DOI] [PubMed] [Google Scholar]
  97. Chan-Yeung M., Chang J. H., Manfreda J., Ferguson A., Becker A. Changes in peak flow, symptom score, and the use of medications during acute exacerbations of asthma. Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):889–893. doi: 10.1164/ajrccm.154.4.8887581. [DOI] [PubMed] [Google Scholar]
  98. Chan-Yeung M., Malo J. L. Occupational asthma. N Engl J Med. 1995 Jul 13;333(2):107–112. doi: 10.1056/NEJM199507133330207. [DOI] [PubMed] [Google Scholar]
  99. Chapman K. R. The choice of inhalers in adults and children over six. J Aerosol Med. 1995 Summer;8 (Suppl 2):S27–S36. doi: 10.1089/jam.1995.8.suppl_2.s-27. [DOI] [PubMed] [Google Scholar]
  100. Charlton I., Charlton G., Broomfield J., Mullee M. A. Evaluation of peak flow and symptoms only self management plans for control of asthma in general practice. BMJ. 1990 Dec 15;301(6765):1355–1359. doi: 10.1136/bmj.301.6765.1355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Charlton I., Charlton G., Broomfield J., Mullee M. A. Evaluation of peak flow and symptoms only self management plans for control of asthma in general practice. BMJ. 1990 Dec 15;301(6765):1355–1359. doi: 10.1136/bmj.301.6765.1355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Charous B. L. Open study of hydroxychloroquine in the treatment of severe symptomatic or corticosteroid-dependent asthma. Ann Allergy. 1990 Jul;65(1):53–58. [PubMed] [Google Scholar]
  103. Cheong B., Reynolds S. R., Rajan G., Ward M. J. Intravenous beta agonist in severe acute asthma. BMJ. 1988 Aug 13;297(6646):448–450. doi: 10.1136/bmj.297.6646.448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Cheung D., Timmers M. C., Zwinderman A. H., Bel E. H., Dijkman J. H., Sterk P. J. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med. 1992 Oct 22;327(17):1198–1203. doi: 10.1056/NEJM199210223271703. [DOI] [PubMed] [Google Scholar]
  105. Chilmonczyk B. A., Salmun L. M., Megathlin K. N., Neveux L. M., Palomaki G. E., Knight G. J., Pulkkinen A. J., Haddow J. E. Association between exposure to environmental tobacco smoke and exacerbations of asthma in children. N Engl J Med. 1993 Jun 10;328(23):1665–1669. doi: 10.1056/NEJM199306103282303. [DOI] [PubMed] [Google Scholar]
  106. Chou K. J., Cunningham S. J., Crain E. F. Metered-dose inhalers with spacers vs nebulizers for pediatric asthma. Arch Pediatr Adolesc Med. 1995 Feb;149(2):201–205. doi: 10.1001/archpedi.1995.02170140083015. [DOI] [PubMed] [Google Scholar]
  107. Choudhury A. H., Gordian M. E., Morris S. S. Associations between respiratory illness and PM10 air pollution. Arch Environ Health. 1997 Mar-Apr;52(2):113–117. doi: 10.1080/00039899709602873. [DOI] [PubMed] [Google Scholar]
  108. Chua H. L., Collis G. G., Newbury A. M., Chan K., Bower G. D., Sly P. D., Le Souef P. N. The influence of age on aerosol deposition in children with cystic fibrosis. Eur Respir J. 1994 Dec;7(12):2185–2191. doi: 10.1183/09031936.94.07122185. [DOI] [PubMed] [Google Scholar]
  109. Ciarallo L., Sauer A. H., Shannon M. W. Intravenous magnesium therapy for moderate to severe pediatric asthma: results of a randomized, placebo-controlled trial. J Pediatr. 1996 Dec;129(6):809–814. doi: 10.1016/s0022-3476(96)70023-9. [DOI] [PubMed] [Google Scholar]
  110. Clarfield A. M., Kogan S., Bergman H., Shapiro D. E., Beaudet M. P. Do consensus conferences influence their participants? CMAJ. 1996 Feb 1;154(3):331–336. [PMC free article] [PubMed] [Google Scholar]
  111. Clark D. J., Lipworth B. J. Dose-response of inhaled drugs in asthma. An update. Clin Pharmacokinet. 1997 Jan;32(1):58–74. doi: 10.2165/00003088-199732010-00003. [DOI] [PubMed] [Google Scholar]
  112. Clark D. J., Lipworth B. J. Effect of multiple actuations, delayed inhalation and antistatic treatment on the lung bioavailability of salbutamol via a spacer device. Thorax. 1996 Oct;51(10):981–984. doi: 10.1136/thx.51.10.981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Clark D. J., Lipworth B. J. Lung bioavailability of chlorofluorocarbon free, dry powder and chlorofluorocarbon containing formulations of salbutamol. Br J Clin Pharmacol. 1996 Mar;41(3):247–249. doi: 10.1111/j.1365-2125.1996.tb00191.x. [DOI] [PubMed] [Google Scholar]
  114. Cloud M. L., Enas G. C., Kemp J., Platts-Mills T., Altman L. C., Townley R., Tinkelman D., King T., Jr, Middleton E., Sheffer A. L. A specific LTD4/LTE4-receptor antagonist improves pulmonary function in patients with mild, chronic asthma. Am Rev Respir Dis. 1989 Nov;140(5):1336–1339. doi: 10.1164/ajrccm/140.5.1336. [DOI] [PubMed] [Google Scholar]
  115. Coady T. J., Davies H. J., Barnes P. Evaluation of a breath actuated pressurized aerosol. Clin Allergy. 1976 Jan;6(1):1–6. doi: 10.1111/j.1365-2222.1976.tb01406.x. [DOI] [PubMed] [Google Scholar]
  116. Cockcroft D. W., Killian D. N., Mellon J. J., Hargreave F. E. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy. 1977 May;7(3):235–243. doi: 10.1111/j.1365-2222.1977.tb01448.x. [DOI] [PubMed] [Google Scholar]
  117. Cockcroft D. W., McParland C. P., Britto S. A., Swystun V. A., Rutherford B. C. Regular inhaled salbutamol and airway responsiveness to allergen. Lancet. 1993 Oct 2;342(8875):833–837. doi: 10.1016/0140-6736(93)92695-p. [DOI] [PubMed] [Google Scholar]
  118. Cockcroft D. W., Swystun V. A. Asthma control versus asthma severity. J Allergy Clin Immunol. 1996 Dec;98(6 Pt 1):1016–1018. doi: 10.1016/s0091-6749(96)80185-0. [DOI] [PubMed] [Google Scholar]
  119. Cockcroft D. W., Swystun V. A. Asthma control versus asthma severity. J Allergy Clin Immunol. 1996 Dec;98(6 Pt 1):1016–1018. doi: 10.1016/s0091-6749(96)80185-0. [DOI] [PubMed] [Google Scholar]
  120. Cockcroft D. W., Swystun V. A. Asthma control versus asthma severity. J Allergy Clin Immunol. 1996 Dec;98(6 Pt 1):1016–1018. doi: 10.1016/s0091-6749(96)80185-0. [DOI] [PubMed] [Google Scholar]
  121. Colacone A., Afilalo M., Wolkove N., Kreisman H. A comparison of albuterol administered by metered dose inhaler (and holding chamber) or wet nebulizer in acute asthma. Chest. 1993 Sep;104(3):835–841. doi: 10.1378/chest.104.3.835. [DOI] [PubMed] [Google Scholar]
  122. Coleman R. A., Eglen R. M., Jones R. L., Narumiya S., Shimizu T., Smith W. L., Dahlén S. E., Drazen J. M., Gardiner P. J., Jackson W. T. Prostanoid and leukotriene receptors: a progress report from the IUPHAR working parties on classification and nomenclature. Adv Prostaglandin Thromboxane Leukot Res. 1995;23:283–285. [PubMed] [Google Scholar]
  123. Coleman R. A., Johnson M., Nials A. T., Vardey C. J. Exosites: their current status, and their relevance to the duration of action of long-acting beta 2-adrenoceptor agonists. Trends Pharmacol Sci. 1996 Sep;17(9):324–330. [PubMed] [Google Scholar]
  124. Collis G. G., Cole C. H., Le Souëf P. N. Dilution of nebulised aerosols by air entrainment in children. Lancet. 1990 Aug 11;336(8711):341–343. doi: 10.1016/0140-6736(90)91880-j. [DOI] [PubMed] [Google Scholar]
  125. Connolly M. J., Crowley J. J., Charan N. B., Nielson C. P., Vestal R. E. Reduced subjective awareness of bronchoconstriction provoked by methacholine in elderly asthmatic and normal subjects as measured on a simple awareness scale. Thorax. 1992 Jun;47(6):410–413. doi: 10.1136/thx.47.6.410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  126. Connolly M. J. Inhaler technique of elderly patients: comparison of metered-dose inhalers and large volume spacer devices. Age Ageing. 1995 May;24(3):190–192. doi: 10.1093/ageing/24.3.190. [DOI] [PubMed] [Google Scholar]
  127. Corbridge T. C., Hall J. B. The assessment and management of adults with status asthmaticus. Am J Respir Crit Care Med. 1995 May;151(5):1296–1316. doi: 10.1164/ajrccm.151.5.7735578. [DOI] [PubMed] [Google Scholar]
  128. Corre K. A., Rothstein R. J. Assessing severity of adult asthma and need for hospitalization. Ann Emerg Med. 1985 Jan;14(1):45–52. doi: 10.1016/s0196-0644(85)80735-6. [DOI] [PubMed] [Google Scholar]
  129. Corssen G., Gutierrez J., Reves J. G., Huber F. C., Jr Ketamine in the anesthetic management of asthmatic patients. Anesth Analg. 1972 Jul-Aug;51(4):588–596. [PubMed] [Google Scholar]
  130. Costa J. C., Plácido J. L., Silva J. P., Delgado L., Vaz M. Effects of immunotherapy on symptoms, PEFR, spirometry, and airway responsiveness in patients with allergic asthma to house-dust mites (D. pteronyssinus) on inhaled steroid therapy. Allergy. 1996 Apr;51(4):238–244. doi: 10.1111/j.1398-9995.1996.tb04599.x. [DOI] [PubMed] [Google Scholar]
  131. Coté J., Cartier A., Robichaud P., Boutin H., Malo J. L., Rouleau M., Fillion A., Lavallée M., Krusky M., Boulet L. P. Influence on asthma morbidity of asthma education programs based on self-management plans following treatment optimization. Am J Respir Crit Care Med. 1997 May;155(5):1509–1514. doi: 10.1164/ajrccm.155.5.9154850. [DOI] [PubMed] [Google Scholar]
  132. Cowan S., Morin S., Ernst P. Bisphosphonates and glucocorticoid-induced osteoporosis: implications for patients with respiratory diseases. Thorax. 1998 May;53(5):331–332. doi: 10.1136/thx.53.5.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Cowie R. L., Revitt S. G., Underwood M. F., Field S. K. The effect of a peak flow-based action plan in the prevention of exacerbations of asthma. Chest. 1997 Dec;112(6):1534–1538. doi: 10.1378/chest.112.6.1534. [DOI] [PubMed] [Google Scholar]
  134. Cowie R. L., Revitt S. G., Underwood M. F., Field S. K. The effect of a peak flow-based action plan in the prevention of exacerbations of asthma. Chest. 1997 Dec;112(6):1534–1538. doi: 10.1378/chest.112.6.1534. [DOI] [PubMed] [Google Scholar]
  135. Crane J., Pearce N., Burgess C., Woodman K., Robson B., Beasley R. Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol. 1992 Aug;21(4):737–744. doi: 10.1093/ije/21.4.737. [DOI] [PubMed] [Google Scholar]
  136. Creticos P. S., Reed C. E., Norman P. S., Khoury J., Adkinson N. F., Jr, Buncher C. R., Busse W. W., Bush R. K., Gadde J., Li J. T. Ragweed immunotherapy in adult asthma. N Engl J Med. 1996 Feb 22;334(8):501–506. doi: 10.1056/NEJM199602223340804. [DOI] [PubMed] [Google Scholar]
  137. Crimi E., Orefice U., De Benedetto F., Grassi V., Brusasco V. Nedocromil sodium versus theophylline in the treatment of reversible obstructive airway disease. Ann Allergy Asthma Immunol. 1995 Jun;74(6):501–508. [PubMed] [Google Scholar]
  138. Croce J., Negreiros E. B., Mazzei J. A., Isturiz G. A double-blind, placebo-controlled comparison of sodium cromoglycate and ketotifen in the treatment of childhood asthma. Allergy. 1995 Jun;50(6):524–527. doi: 10.1111/j.1398-9995.1995.tb01191.x. [DOI] [PubMed] [Google Scholar]
  139. Crompton G. K. Problems patients have using pressurized aerosol inhalers. Eur J Respir Dis Suppl. 1982;119:101–104. [PubMed] [Google Scholar]
  140. Cumming R. G., Mitchell P. Inhaled corticosteroids and cataract: prevalence, prevention and management. Drug Saf. 1999 Jan;20(1):77–84. doi: 10.2165/00002018-199920010-00007. [DOI] [PubMed] [Google Scholar]
  141. Cumming R. G., Mitchell P., Leeder S. R. Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med. 1997 Jul 3;337(1):8–14. doi: 10.1056/NEJM199707033370102. [DOI] [PubMed] [Google Scholar]
  142. Cumming R. G., Mitchell P., Leeder S. R. Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med. 1997 Jul 3;337(1):8–14. doi: 10.1056/NEJM199707033370102. [DOI] [PubMed] [Google Scholar]
  143. Cunningham J., O'Connor G. T., Dockery D. W., Speizer F. E. Environmental tobacco smoke, wheezing, and asthma in children in 24 communities. Am J Respir Crit Care Med. 1996 Jan;153(1):218–224. doi: 10.1164/ajrccm.153.1.8542119. [DOI] [PubMed] [Google Scholar]
  144. Cyr T. D., Graham S. J., Li K. Y., Lovering E. G. Low first-spray drug content in albuterol metered-dose inhalers. Pharm Res. 1991 May;8(5):658–660. doi: 10.1023/a:1015825311750. [DOI] [PubMed] [Google Scholar]
  145. Dahlén B., Margolskee D. J., Zetterström O., Dahlén S. E. Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects. Thorax. 1993 Dec;48(12):1205–1210. doi: 10.1136/thx.48.12.1205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  146. Dalby R. N., Somaraju S., Chavan V. S., Jarvis D. Evaluation of aerosol drug output from the OptiChamber and AeroChamber spacers in a model system. J Asthma. 1998;35(2):173–177. doi: 10.3109/02770909809068205. [DOI] [PubMed] [Google Scholar]
  147. Darioli R., Perret C. Mechanical controlled hypoventilation in status asthmaticus. Am Rev Respir Dis. 1984 Mar;129(3):385–387. doi: 10.1164/arrd.1984.129.3.385. [DOI] [PubMed] [Google Scholar]
  148. Daugbjerg P., Nielsen K. G., Skov M., Bisgaard H. Duration of action of formoterol and salbutamol dry-powder inhalation in prevention of exercise-induced asthma in children. Acta Paediatr. 1996 Jun;85(6):684–687. doi: 10.1111/j.1651-2227.1996.tb14125.x. [DOI] [PubMed] [Google Scholar]
  149. Davis D. A., Taylor-Vaisey A. Translating guidelines into practice. A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. CMAJ. 1997 Aug 15;157(4):408–416. [PMC free article] [PubMed] [Google Scholar]
  150. Dawood A. G., Hendry A. T., Walker S. R. The combined use of betamethasone valerate and sodium cromoglycate in the treatment of asthma. Clin Allergy. 1977 Mar;7(2):161–165. doi: 10.1111/j.1365-2222.1977.tb01437.x. [DOI] [PubMed] [Google Scholar]
  151. Dawson K. P. The asthma clinical score and oxygen saturation. Aust Clin Rev. 1991;11(1-2):20–21. [PubMed] [Google Scholar]
  152. Delfino R. J., Murphy-Moulton A. M., Burnett R. T., Brook J. R., Becklake M. R. Effects of air pollution on emergency room visits for respiratory illnesses in Montreal, Quebec. Am J Respir Crit Care Med. 1997 Feb;155(2):568–576. doi: 10.1164/ajrccm.155.2.9032196. [DOI] [PubMed] [Google Scholar]
  153. Delfino R. J., Zeiger R. S., Seltzer J. M., Street D. H., Matteucci R. M., Anderson P. R., Koutrakis P. The effect of outdoor fungal spore concentrations on daily asthma severity. Environ Health Perspect. 1997 Jun;105(6):622–635. doi: 10.1289/ehp.97105622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  154. Demissie K., Breckenridge M. B., Rhoads G. G. Infant and maternal outcomes in the pregnancies of asthmatic women. Am J Respir Crit Care Med. 1998 Oct;158(4):1091–1095. doi: 10.1164/ajrccm.158.4.9802053. [DOI] [PubMed] [Google Scholar]
  155. Devalia J. L., Rusznak C., Herdman M. J., Trigg C. J., Tarraf H., Davies R. J. Effect of nitrogen dioxide and sulphur dioxide on airway response of mild asthmatic patients to allergen inhalation. Lancet. 1994 Dec 17;344(8938):1668–1671. doi: 10.1016/s0140-6736(94)90458-8. [DOI] [PubMed] [Google Scholar]
  156. Devi P. R., Kumar L., Singhi S. C., Prasad R., Singh M. Intravenous magnesium sulfate in acute severe asthma not responding to conventional therapy. Indian Pediatr. 1997 May;34(5):389–397. [PubMed] [Google Scholar]
  157. Diaz-Sanchez D., Dotson A. R., Takenaka H., Saxon A. Diesel exhaust particles induce local IgE production in vivo and alter the pattern of IgE messenger RNA isoforms. J Clin Invest. 1994 Oct;94(4):1417–1425. doi: 10.1172/JCI117478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  158. Diaz-Sanchez D., Tsien A., Casillas A., Dotson A. R., Saxon A. Enhanced nasal cytokine production in human beings after in vivo challenge with diesel exhaust particles. J Allergy Clin Immunol. 1996 Jul;98(1):114–123. doi: 10.1016/s0091-6749(96)70233-6. [DOI] [PubMed] [Google Scholar]
  159. Diaz-Sanchez D., Tsien A., Fleming J., Saxon A. Combined diesel exhaust particulate and ragweed allergen challenge markedly enhances human in vivo nasal ragweed-specific IgE and skews cytokine production to a T helper cell 2-type pattern. J Immunol. 1997 Mar 1;158(5):2406–2413. [PubMed] [Google Scholar]
  160. Dietemann A., Bessot J. C., Hoyet C., Ott M., Verot A., Pauli G. A double-blind, placebo controlled trial of solidified benzyl benzoate applied in dwellings of asthmatic patients sensitive to mites: clinical efficacy and effect on mite allergens. J Allergy Clin Immunol. 1993 Mar;91(3):738–746. doi: 10.1016/0091-6749(93)90193-j. [DOI] [PubMed] [Google Scholar]
  161. Dillard R. D., Hahn R. A., McCullough D., Carr F. P., Rinkema L. E., Roman C. R., Fleisch J. H. (Phenylmethoxy)phenyl derivatives of omega-oxo- and omega-tetrazolylalkanoic acids and related tetrazoles. Synthesis and evaluation as leukotriene D4 receptor antagonists. J Med Chem. 1991 Sep;34(9):2768–2778. doi: 10.1021/jm00113a014. [DOI] [PubMed] [Google Scholar]
  162. Dixon J. France seeks to curb health costs by fining doctors. BMJ. 1997 Oct 11;315(7113):895–896. doi: 10.1136/bmj.315.7113.895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  163. Downey P., Cox R. Update on the management of status asthmaticus. Curr Opin Pediatr. 1996 Jun;8(3):226–233. doi: 10.1097/00008480-199606000-00006. [DOI] [PubMed] [Google Scholar]
  164. Dowse G. K., Turner K. J., Stewart G. A., Alpers M. P., Woolcock A. J. The association between Dermatophagoides mites and the increasing prevalence of asthma in village communities within the Papua New Guinea highlands. J Allergy Clin Immunol. 1985 Jan;75(1 Pt 1):75–83. doi: 10.1016/0091-6749(85)90016-8. [DOI] [PubMed] [Google Scholar]
  165. Drazen J. M., Israel E., Boushey H. A., Chinchilli V. M., Fahy J. V., Fish J. E., Lazarus S. C., Lemanske R. F., Martin R. J., Peters S. P. Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network. N Engl J Med. 1996 Sep 19;335(12):841–847. doi: 10.1056/NEJM199609193351202. [DOI] [PubMed] [Google Scholar]
  166. Dreborg S., Agrell B., Foucard T., Kjellman N. I., Koivikko A., Nilsson S. A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. I. Clinical results. Allergy. 1986 Feb;41(2):131–140. doi: 10.1111/j.1398-9995.1986.tb00289.x. [DOI] [PubMed] [Google Scholar]
  167. Dreyer E. B. Inhaled steroid use and glaucoma. N Engl J Med. 1993 Dec 9;329(24):1822–1822. doi: 10.1056/nejm199312093292420. [DOI] [PubMed] [Google Scholar]
  168. Ducharme F. M., Davis G. M. Randomized controlled trial of ipratropium bromide and frequent low doses of salbutamol in the management of mild and moderate acute pediatric asthma. J Pediatr. 1998 Oct;133(4):479–485. doi: 10.1016/s0022-3476(98)70054-x. [DOI] [PubMed] [Google Scholar]
  169. Duke T., Kellermann A., Ellis R., Arheart K., Self T. Asthma in the emergency department: impact of a protocol on optimizing therapy. Am J Emerg Med. 1991 Sep;9(5):432–435. doi: 10.1016/0735-6757(91)90208-2. [DOI] [PubMed] [Google Scholar]
  170. Durand-Zaleski I., Colin C., Blum-Boisgard C. An attempt to save money by using mandatory practice guidelines in France. BMJ. 1997 Oct 11;315(7113):943–946. doi: 10.1136/bmj.315.7113.943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  171. Díaz J. E., Dubin R., Gaeta T. J., Pelczar P., Bradley K. Efficacy of atropine sulfate in combination with albuterol in the treatment for acute asthma. Acad Emerg Med. 1997 Feb;4(2):107–113. doi: 10.1111/j.1553-2712.1997.tb03715.x. [DOI] [PubMed] [Google Scholar]
  172. Echeverria M., Gelb A. W., Wexler H. R., Ahmad D., Kenefick P. Enflurane and halothane in status asthmaticus. Chest. 1986 Jan;89(1):152–154. doi: 10.1378/chest.89.1.152. [DOI] [PubMed] [Google Scholar]
  173. Edwards A. M., Stevens M. T. The clinical efficacy of inhaled nedocromil sodium (Tilade) in the treatment of asthma. Eur Respir J. 1993 Jan;6(1):35–41. [PubMed] [Google Scholar]
  174. Ehnert B., Lau-Schadendorf S., Weber A., Buettner P., Schou C., Wahn U. Reducing domestic exposure to dust mite allergen reduces bronchial hyperreactivity in sensitive children with asthma. J Allergy Clin Immunol. 1992 Jul;90(1):135–138. doi: 10.1016/s0091-6749(06)80024-2. [DOI] [PubMed] [Google Scholar]
  175. Eisenberg D. M., Kessler R. C., Foster C., Norlock F. E., Calkins D. R., Delbanco T. L. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med. 1993 Jan 28;328(4):246–252. doi: 10.1056/NEJM199301283280406. [DOI] [PubMed] [Google Scholar]
  176. Engel T., Heinig J. H. Glucocorticosteroid therapy in acute severe asthma--a critical review. Eur Respir J. 1991 Jul;4(7):881–889. [PubMed] [Google Scholar]
  177. Engel W., Freund D. A., Stein J. S., Fletcher R. H. The treatment of patients with asthma by specialists and generalists. Med Care. 1989 Mar;27(3):306–314. doi: 10.1097/00005650-198903000-00009. [DOI] [PubMed] [Google Scholar]
  178. Epstein S. W., Manning C. P., Ashley M. J., Corey P. N. Survey of the clinical use of pressurized aerosol inhalers. Can Med Assoc J. 1979 Apr 7;120(7):813–816. [PMC free article] [PubMed] [Google Scholar]
  179. Epstein S. W., Manning C. P., Ashley M. J., Corey P. N. Survey of the clinical use of pressurized aerosol inhalers. Can Med Assoc J. 1979 Apr 7;120(7):813–816. [PMC free article] [PubMed] [Google Scholar]
  180. Ernst P., Habbick B., Suissa S., Hemmelgarn B., Cockcroft D., Buist A. S., Horwitz R. I., McNutt M., Spitzer W. O. Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity? Am Rev Respir Dis. 1993 Jul;148(1):75–79. doi: 10.1164/ajrccm/148.1.75. [DOI] [PubMed] [Google Scholar]
  181. Ernst P. Inhaled drug delivery: a practical guide to prescribing inhaler devices. Can Respir J. 1998 May-Jun;5(3):180–183. doi: 10.1155/1998/802829. [DOI] [PubMed] [Google Scholar]
  182. Evans D. J., Taylor D. A., Zetterstrom O., Chung K. F., O'Connor B. J., Barnes P. J. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N Engl J Med. 1997 Nov 13;337(20):1412–1418. doi: 10.1056/NEJM199711133372002. [DOI] [PubMed] [Google Scholar]
  183. Evans D., Clark N. M., Feldman C. H., Rips J., Kaplan D., Levison M. J., Wasilewski Y., Levin B., Mellins R. B. A school health education program for children with asthma aged 8-11 years. Health Educ Q. 1987 Fall;14(3):267–279. doi: 10.1177/109019818701400302. [DOI] [PubMed] [Google Scholar]
  184. Everard M. L., Milner A. D. A drying chamber for use with small volume jet nebulizers. Respir Med. 1995 Sep;89(8):567–569. doi: 10.1016/0954-6111(95)90160-4. [DOI] [PubMed] [Google Scholar]
  185. Ewer T. C., Stewart D. E. Improvement in bronchial hyper-responsiveness in patients with moderate asthma after treatment with a hypnotic technique: a randomised controlled trial. Br Med J (Clin Res Ed) 1986 Nov 1;293(6555):1129–1132. doi: 10.1136/bmj.293.6555.1129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  186. Fabbri L. M., Danieli D., Crescioli S., Bevilacqua P., Meli S., Saetta M., Mapp C. E. Fatal asthma in a subject sensitized to toluene diisocyanate. Am Rev Respir Dis. 1988 Jun;137(6):1494–1498. doi: 10.1164/ajrccm/137.6.1494. [DOI] [PubMed] [Google Scholar]
  187. Fanta C. H., Rossing T. H., McFadden E. R., Jr Emergency room of treatment of asthma. Relationships among therapeutic combinations, severity of obstruction and time course of response. Am J Med. 1982 Mar;72(3):416–422. doi: 10.1016/0002-9343(82)90498-3. [DOI] [PubMed] [Google Scholar]
  188. Fanta C. H., Rossing T. H., McFadden E. R., Jr Glucocorticoids in acute asthma. A critical controlled trial. Am J Med. 1983 May;74(5):845–851. doi: 10.1016/0002-9343(83)91076-8. [DOI] [PubMed] [Google Scholar]
  189. Fanta C. H., Rossing T. H., McFadden E. R., Jr Treatment of acute asthma. Is combination therapy with sympathomimetics and methylxanthines indicated? Am J Med. 1986 Jan;80(1):5–10. doi: 10.1016/0002-9343(86)90041-0. [DOI] [PubMed] [Google Scholar]
  190. Farr S. J., Rowe A. M., Rubsamen R., Taylor G. Aerosol deposition in the human lung following administration from a microprocessor controlled pressurised metered dose inhaler. Thorax. 1995 Jun;50(6):639–644. doi: 10.1136/thx.50.6.639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  191. Faurschou P., Bing J., Edman G., Engel A. M. Comparison between sodium cromoglycate (MDI: metered-dose inhaler) and beclomethasone dipropionate (MDI) in treatment of adult patients with mild to moderate bronchial asthma. A double-blind, double-dummy randomized, parallel-group study. Allergy. 1994 Sep;49(8):659–663. doi: 10.1111/j.1398-9995.1994.tb00136.x. [DOI] [PubMed] [Google Scholar]
  192. Feder G., Griffiths C., Highton C., Eldridge S., Spence M., Southgate L. Do clinical guidelines introduced with practice based education improve care of asthmatic and diabetic patients? A randomised controlled trial in general practices in east London. BMJ. 1995 Dec 2;311(7018):1473–1478. doi: 10.1136/bmj.311.7018.1473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  193. Fireman P., Friday G. A., Gira C., Vierthaler W. A., Michaels L. Teaching self-management skills to asthmatic children and their parents in an ambulatory care setting. Pediatrics. 1981 Sep;68(3):341–348. [PubMed] [Google Scholar]
  194. Fishwick D., Pearce N., D'Souza W., Lewis S., Town I., Armstrong R., Kogevinas M., Crane J. Occupational asthma in New Zealanders: a population based study. Occup Environ Med. 1997 May;54(5):301–306. doi: 10.1136/oem.54.5.301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  195. FitzGerald J. M., Grunfeld A., Pare P. D., Levy R. D., Newhouse M. T., Hodder R., Chapman K. R. The clinical efficacy of combination nebulized anticholinergic and adrenergic bronchodilators vs nebulized adrenergic bronchodilator alone in acute asthma. Canadian Combivent Study Group. Chest. 1997 Feb;111(2):311–315. doi: 10.1378/chest.111.2.311. [DOI] [PubMed] [Google Scholar]
  196. FitzGerald J. M., Macklem P. Fatal asthma. Annu Rev Med. 1996;47:161–168. doi: 10.1146/annurev.med.47.1.161. [DOI] [PubMed] [Google Scholar]
  197. FitzGerald J. M., Spier S., Ernst P. Evidence-based asthma guidelines. Chest. 1996 Dec;110(6):1382–1383. doi: 10.1378/chest.110.6.1382. [DOI] [PubMed] [Google Scholar]
  198. Fjellbirkeland L., Gulsvik A., Palmer J. B. The efficacy and tolerability of inhaled salmeterol and individually dose-titrated, sustained-release theophylline in patients with reversible airways disease. Respir Med. 1994 Sep;88(8):599–607. doi: 10.1016/s0954-6111(05)80008-3. [DOI] [PubMed] [Google Scholar]
  199. Fletcher C. M., Pride N. B. Definitions of emphysema, chronic bronchitis, asthma, and airflow obstruction: 25 years on from the Ciba symposium. Thorax. 1984 Feb;39(2):81–85. doi: 10.1136/thx.39.2.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  200. Ford-Hutchinson A. W. FLAP: a novel drug target for inhibiting the synthesis of leukotrienes. Trends Pharmacol Sci. 1991 Feb;12(2):68–70. doi: 10.1016/0165-6147(91)90500-r. [DOI] [PubMed] [Google Scholar]
  201. Friedman B. S., Bel E. H., Buntinx A., Tanaka W., Han Y. H., Shingo S., Spector R., Sterk P. Oral leukotriene inhibitor (MK-886) blocks allergen-induced airway responses. Am Rev Respir Dis. 1993 Apr;147(4):839–844. doi: 10.1164/ajrccm/147.4.839. [DOI] [PubMed] [Google Scholar]
  202. Fuglsang G., Pedersen S. Comparison of Nebuhaler and nebulizer treatment of acute severe asthma in children. Eur J Respir Dis. 1986 Aug;69(2):109–113. [PubMed] [Google Scholar]
  203. Fujimaki H., Nohara O., Ichinose T., Watanabe N., Saito S. IL-4 production in mediastinal lymph node cells in mice intratracheally instilled with diesel exhaust particulates and antigen. Toxicology. 1994 Sep 6;92(1-3):261–268. doi: 10.1016/0300-483x(94)90182-1. [DOI] [PubMed] [Google Scholar]
  204. Fujimaki H., Saneyoshi K., Nohara O., Shiraishi F., Imai T. Intranasal instillation of diesel exhaust particulates and antigen in mice modulated cytokine productions in cervical lymph node cells. Int Arch Allergy Immunol. 1995 Nov;108(3):268–273. doi: 10.1159/000237163. [DOI] [PubMed] [Google Scholar]
  205. Fujimaki H., Saneyoshi K., Shiraishi F., Imai T., Endo T. Inhalation of diesel exhaust enhances antigen-specific IgE antibody production in mice. Toxicology. 1997 Jan 15;116(1-3):227–233. doi: 10.1016/s0300-483x(96)03539-1. [DOI] [PubMed] [Google Scholar]
  206. Fung K. P., Chow O. K., So S. Y. Attenuation of exercise-induced asthma by acupuncture. Lancet. 1986 Dec 20;2(8521-22):1419–1422. [PubMed] [Google Scholar]
  207. Furukawa C. T., DuHamel T. R., Weimer L., Shapiro G. G., Pierson W. E., Bierman C. W. Cognitive and behavioral findings in children taking theophylline. J Allergy Clin Immunol. 1988 Jan;81(1):83–88. doi: 10.1016/0091-6749(88)90224-2. [DOI] [PubMed] [Google Scholar]
  208. Furukawa C. T., Shapiro G. G., Bierman C. W., Kraemer M. J., Ward D. J., Pierson W. E. A double-blind study comparing the effectiveness of cromolyn sodium and sustained-release theophylline in childhood asthma. Pediatrics. 1984 Oct;74(4):453–459. [PubMed] [Google Scholar]
  209. Gaddy J. N., Margolskee D. J., Bush R. K., Williams V. C., Busse W. W. Bronchodilation with a potent and selective leukotriene D4 (LTD4) receptor antagonist (MK-571) in patients with asthma. Am Rev Respir Dis. 1992 Aug;146(2):358–363. doi: 10.1164/ajrccm/146.2.358. [DOI] [PubMed] [Google Scholar]
  210. Galant S. P., Lawrence M., Meltzer E. O., Tomasko M., Baker K. A., Kellerman D. J. Fluticasone propionate compared with theophylline for mild-to-moderate asthma. Ann Allergy Asthma Immunol. 1996 Aug;77(2):112–118. doi: 10.1016/S1081-1206(10)63496-5. [DOI] [PubMed] [Google Scholar]
  211. Garbe E., LeLorier J., Boivin J. F., Suissa S. Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. JAMA. 1997 Mar 5;277(9):722–727. [PubMed] [Google Scholar]
  212. Garbe E., LeLorier J., Boivin J. F., Suissa S. Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. JAMA. 1997 Mar 5;277(9):722–727. [PubMed] [Google Scholar]
  213. Garrett J., Fenwick J. M., Taylor G., Mitchell E., Stewart J., Rea H. Prospective controlled evaluation of the effect of a community based asthma education centre in a multiracial working class neighbourhood. Thorax. 1994 Oct;49(10):976–983. doi: 10.1136/thx.49.10.976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  214. Gauvreau G. M., Jordana M., Watson R. M., Cockroft D. W., O'Byrne P. M. Effect of regular inhaled albuterol on allergen-induced late responses and sputum eosinophils in asthmatic subjects. Am J Respir Crit Care Med. 1997 Dec;156(6):1738–1745. doi: 10.1164/ajrccm.156.6.96-08042. [DOI] [PubMed] [Google Scholar]
  215. Geelhoed G. C., Landau L. I., Le Souëf P. N. Evaluation of SaO2 as a predictor of outcome in 280 children presenting with acute asthma. Ann Emerg Med. 1994 Jun;23(6):1236–1241. doi: 10.1016/s0196-0644(94)70347-7. [DOI] [PubMed] [Google Scholar]
  216. Gelber L. E., Seltzer L. H., Bouzoukis J. K., Pollart S. M., Chapman M. D., Platts-Mills T. A. Sensitization and exposure to indoor allergens as risk factors for asthma among patients presenting to hospital. Am Rev Respir Dis. 1993 Mar;147(3):573–578. doi: 10.1164/ajrccm/147.3.573. [DOI] [PubMed] [Google Scholar]
  217. Gern J. E., Calhoun W., Swenson C., Shen G., Busse W. W. Rhinovirus infection preferentially increases lower airway responsiveness in allergic subjects. Am J Respir Crit Care Med. 1997 Jun;155(6):1872–1876. doi: 10.1164/ajrccm.155.6.9196088. [DOI] [PubMed] [Google Scholar]
  218. Gerritsen J., Koëter G. H., de Monchy J. G., Knol K. Allergy in subjects with asthma from childhood to adulthood. J Allergy Clin Immunol. 1990 Jan;85(1 Pt 1):116–125. doi: 10.1016/0091-6749(90)90232-s. [DOI] [PubMed] [Google Scholar]
  219. Gibson P. G., Dolovich J., Denburg J. A., Girgis-Gabardo A., Hargreave F. E. Sputum cell counts in airway disease: a useful sampling technique. Agents Actions Suppl. 1990;30:161–172. doi: 10.1007/978-3-0348-7488-5_12. [DOI] [PubMed] [Google Scholar]
  220. Gibson P. G., Dolovich J., Denburg J., Ramsdale E. H., Hargreave F. E. Chronic cough: eosinophilic bronchitis without asthma. Lancet. 1989 Jun 17;1(8651):1346–1348. doi: 10.1016/s0140-6736(89)92801-8. [DOI] [PubMed] [Google Scholar]
  221. Gibson P. G., Wlodarczyk J. H., Borgas T. Drug delivery in asthma: a comparison of spacers with a jet nebuliser. Aust N Z J Med. 1995 Aug;25(4):324–329. doi: 10.1111/j.1445-5994.1995.tb01897.x. [DOI] [PubMed] [Google Scholar]
  222. Gilmour M. I. Interaction of air pollutants and pulmonary allergic responses in experimental animals. Toxicology. 1995 Dec 28;105(2-3):335–342. doi: 10.1016/0300-483x(95)03230-d. [DOI] [PubMed] [Google Scholar]
  223. Givens C. D., Jr, Marini J. J. Transbronchial needle aspiration of a bronchial carcinoid tumor. Chest. 1985 Jul;88(1):152–153. doi: 10.1378/chest.88.1.152. [DOI] [PubMed] [Google Scholar]
  224. Gleason J. F., Bhartia P. K., Herman J. R., McPeters R., Newman P., Stolarski R. S., Flynn L., Labow G., Larko D., Seftor C., Wellemeyer C., Komhyr W. D., Miller A. J., Planet W. Record low global ozone in 1992. Science. 1993 Apr 23;260(5107):523–526. doi: 10.1126/science.260.5107.523. [DOI] [PubMed] [Google Scholar]
  225. Gleeson J. G., Price J. F. Nebuhaler technique. Br J Dis Chest. 1988 Apr;82(2):172–174. doi: 10.1016/0007-0971(88)90039-3. [DOI] [PubMed] [Google Scholar]
  226. Godfrey S. The relative merits of cromolyn sodium and high-dose theophylline therapy in childhood asthma. J Allergy Clin Immunol. 1980 Feb;65(2):97–104. doi: 10.1016/0091-6749(80)90192-x. [DOI] [PubMed] [Google Scholar]
  227. Goldin J. G., Bateman E. D. Does nedocromil sodium have a steroid sparing effect in adult asthmatic patients requiring maintenance oral corticosteroids? Thorax. 1988 Dec;43(12):982–986. doi: 10.1136/thx.43.12.982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  228. Goren A., Noviski N., Avital A., Maayan C., Stahl E., Godfrey S., Springer C. Assessment of the ability of young children to use a powder inhaler device (Turbuhaler). Pediatr Pulmonol. 1994 Aug;18(2):77–80. doi: 10.1002/ppul.1950180204. [DOI] [PubMed] [Google Scholar]
  229. Gortmaker S. L., Walker D. K., Jacobs F. H., Ruch-Ross H. Parental smoking and the risk of childhood asthma. Am J Public Health. 1982 Jun;72(6):574–579. doi: 10.2105/ajph.72.6.574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  230. Grant S. M., Goa K. L., Fitton A., Sorkin E. M. Ketotifen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders. Drugs. 1990 Sep;40(3):412–448. doi: 10.2165/00003495-199040030-00006. [DOI] [PubMed] [Google Scholar]
  231. Greco P. J., Eisenberg J. M. Changing physicians' practices. N Engl J Med. 1993 Oct 21;329(17):1271–1273. doi: 10.1056/NEJM199310213291714. [DOI] [PubMed] [Google Scholar]
  232. Green S. A., Spasoff A. P., Coleman R. A., Johnson M., Liggett S. B. Sustained activation of a G protein-coupled receptor via "anchored" agonist binding. Molecular localization of the salmeterol exosite within the 2-adrenergic receptor. J Biol Chem. 1996 Sep 27;271(39):24029–24035. doi: 10.1074/jbc.271.39.24029. [DOI] [PubMed] [Google Scholar]
  233. Green S. M., Rothrock S. G. Intravenous magnesium for acute asthma: failure to decrease emergency treatment duration or need for hospitalization. Ann Emerg Med. 1992 Mar;21(3):260–265. doi: 10.1016/s0196-0644(05)80885-6. [DOI] [PubMed] [Google Scholar]
  234. Greening A. P., Ind P. W., Northfield M., Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group. Lancet. 1994 Jul 23;344(8917):219–224. doi: 10.1016/s0140-6736(94)92996-3. [DOI] [PubMed] [Google Scholar]
  235. Greif J., Fink G., Smorzik Y., Topilsky M., Bruderman I., Spitzer S. A. Nedocromil sodium and placebo in the treatment of bronchial asthma. A multicenter, double-blind, parallel-group comparison. Chest. 1989 Sep;96(3):583–588. doi: 10.1378/chest.96.3.583. [DOI] [PubMed] [Google Scholar]
  236. Griffin M., Weiss J. W., Leitch A. G., McFadden E. R., Jr, Corey E. J., Austen K. F., Drazen J. M. Effects of leukotriene D on the airways in asthma. N Engl J Med. 1983 Feb 24;308(8):436–439. doi: 10.1056/NEJM198302243080807. [DOI] [PubMed] [Google Scholar]
  237. Grimshaw J. M., Russell I. T. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet. 1993 Nov 27;342(8883):1317–1322. doi: 10.1016/0140-6736(93)92244-n. [DOI] [PubMed] [Google Scholar]
  238. Grimshaw J., Freemantle N., Wallace S., Russell I., Hurwitz B., Watt I., Long A., Sheldon T. Developing and implementing clinical practice guidelines. Qual Health Care. 1995 Mar;4(1):55–64. doi: 10.1136/qshc.4.1.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  239. Gross N. J. Ipratropium bromide. N Engl J Med. 1988 Aug 25;319(8):486–494. doi: 10.1056/NEJM198808253190806. [DOI] [PubMed] [Google Scholar]
  240. Grove A., Allam C., McFarlane L. C., McPhate G., Jackson C. M., Lipworth B. J. A comparison of the systemic bioactivity of inhaled budesonide and fluticasone propionate in normal subjects. Br J Clin Pharmacol. 1994 Dec;38(6):527–532. doi: 10.1111/j.1365-2125.1994.tb04394.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  241. Grove A., Lipworth B. J. Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients. Lancet. 1995 Jul 22;346(8969):201–206. doi: 10.1016/s0140-6736(95)91265-7. [DOI] [PubMed] [Google Scholar]
  242. Grove A., Lipworth B. J. Effects of prior treatment with salmeterol and formoterol on airway and systemic beta 2 responses to fenoterol. Thorax. 1996 Jun;51(6):585–589. doi: 10.1136/thx.51.6.585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  243. Grünberg K., Smits H. H., Timmers M. C., de Klerk E. P., Dolhain R. J., Dick E. C., Hiemstra P. S., Sterk P. J. Experimental rhinovirus 16 infection. Effects on cell differentials and soluble markers in sputum in asthmatic subjects. Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):609–616. doi: 10.1164/ajrccm.156.2.9610079. [DOI] [PubMed] [Google Scholar]
  244. Guyatt G. H., Juniper E. F., Griffith L. E., Feeny D. H., Ferrie P. J. Children and adult perceptions of childhood asthma. Pediatrics. 1997 Feb;99(2):165–168. doi: 10.1542/peds.99.2.165. [DOI] [PubMed] [Google Scholar]
  245. Haahtela T., Järvinen M., Kava T., Kiviranta K., Koskinen S., Lehtonen K., Nikander K., Persson T., Reinikainen K., Selroos O. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med. 1991 Aug 8;325(6):388–392. doi: 10.1056/NEJM199108083250603. [DOI] [PubMed] [Google Scholar]
  246. Haahtela T., Järvinen M., Kava T., Kiviranta K., Koskinen S., Lehtonen K., Nikander K., Persson T., Selroos O., Sovijärvi A. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med. 1994 Sep 15;331(11):700–705. doi: 10.1056/NEJM199409153311103. [DOI] [PubMed] [Google Scholar]
  247. Haley K. J., Drazen J. M. Inflammation and airway function in asthma: what you see is not necessarily what you get. Am J Respir Crit Care Med. 1998 Jan;157(1):1–3. doi: 10.1164/ajrccm.157.1.ed-19. [DOI] [PubMed] [Google Scholar]
  248. Hamilton A. L., Watson R. M., Wyile G., O'Byrne P. M. Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005. Thorax. 1997 Apr;52(4):348–354. doi: 10.1136/thx.52.4.348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  249. Hanania N. A., Chapman K. R., Sturtridge W. C., Szalai J. P., Kesten S. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol. 1995 Nov;96(5 Pt 1):571–579. doi: 10.1016/s0091-6749(95)70254-7. [DOI] [PubMed] [Google Scholar]
  250. Hanania N. A., Wittman R., Kesten S., Chapman K. R. Medical personnel's knowledge of and ability to use inhaling devices. Metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers. Chest. 1994 Jan;105(1):111–116. doi: 10.1378/chest.105.1.111. [DOI] [PubMed] [Google Scholar]
  251. Hansen O. R., Pedersen S. Optimal inhalation technique with terbutaline Turbuhaler. Eur Respir J. 1989 Jul;2(7):637–639. [PubMed] [Google Scholar]
  252. Hargreave F. E., Dolovich J., Newhouse M. T. The assessment and treatment of asthma: a conference report. J Allergy Clin Immunol. 1990 Jun;85(6):1098–1111. doi: 10.1016/0091-6749(90)90056-a. [DOI] [PubMed] [Google Scholar]
  253. Hargreave F. E., Dolovich J., Newhouse M. T. The assessment and treatment of asthma: a conference report. J Allergy Clin Immunol. 1990 Jun;85(6):1098–1111. doi: 10.1016/0091-6749(90)90056-a. [DOI] [PubMed] [Google Scholar]
  254. Hargreave F. E., Dolovich J., Newhouse M. T. The assessment and treatment of asthma: a conference report. J Allergy Clin Immunol. 1990 Jun;85(6):1098–1111. doi: 10.1016/0091-6749(90)90056-a. [DOI] [PubMed] [Google Scholar]
  255. Hargreave F. E., Dolovich J., Newhouse M. T. The assessment and treatment of asthma: a conference report. J Allergy Clin Immunol. 1990 Jun;85(6):1098–1111. doi: 10.1016/0091-6749(90)90056-a. [DOI] [PubMed] [Google Scholar]
  256. Harju T., Keistinen T., Tuuponen T., Kivelä S. L. Hospital admissions of asthmatics by age and sex. Allergy. 1996 Oct;51(10):693–696. [PubMed] [Google Scholar]
  257. Harper G. D., Neill P., Vathenen A. S., Cookson J. B., Ebden P. A comparison of inhaled beclomethasone dipropionate and nedocromil sodium as additional therapy in asthma. Respir Med. 1990 Nov;84(6):463–469. doi: 10.1016/s0954-6111(08)80110-2. [DOI] [PubMed] [Google Scholar]
  258. Harrison L. I., Dahl D. R., Cline A., Chang S. F., Machacek J., Nelson J., Kannianinen C., Purrington A. Pharmacokinetics and dose proportionality of beclomethasone from three strengths of a CFC-free beclomethasone dipropionate metered-dose inhaler. Biopharm Drug Dispos. 1997 Oct;18(7):635–643. doi: 10.1002/(sici)1099-081x(199710)18:7<635::aid-bdd53>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  259. Hattevig G., Kjellman B., Björkstén B. Clinical symptoms and IgE responses to common food proteins and inhalants in the first 7 years of life. Clin Allergy. 1987 Nov;17(6):571–578. doi: 10.1111/j.1365-2222.1987.tb02053.x. [DOI] [PubMed] [Google Scholar]
  260. Hayden M. L., Perzanowski M., Matheson L., Scott P., Call R. S., Platts-Mills T. A. Dust mite allergen avoidance in the treatment of hospitalized children with asthma. Ann Allergy Asthma Immunol. 1997 Nov;79(5):437–442. doi: 10.1016/S1081-1206(10)63040-2. [DOI] [PubMed] [Google Scholar]
  261. Hayward R. S., Guyatt G. H., Moore K. A., McKibbon K. A., Carter A. O. Canadian physicians' attitudes about and preferences regarding clinical practice guidelines. CMAJ. 1997 Jun 15;156(12):1715–1723. [PMC free article] [PubMed] [Google Scholar]
  262. Hedman J., Seideman P., Albertioni F., Stenius-Aarniala B. Controlled trial of methotrexate in patients with severe chronic asthma. Eur J Clin Pharmacol. 1996;49(5):347–349. doi: 10.1007/BF00203775. [DOI] [PubMed] [Google Scholar]
  263. Heins M., Kurtin L., Oellerich M., Maes R., Sybrecht G. W. Nocturnal asthma: slow-release terbutaline versus slow-release theophylline therapy. Eur Respir J. 1988 Apr;1(4):306–310. [PubMed] [Google Scholar]
  264. Hendeles L., Weinberger M. Theophylline. A "state of the art" review. Pharmacotherapy. 1983 Jan-Feb;3(1):2–44. doi: 10.1002/j.1875-9114.1983.tb04531.x. [DOI] [PubMed] [Google Scholar]
  265. Higgins R. M., Stradling J. R., Lane D. J. Should ipratropium bromide be added to beta-agonists in treatment of acute severe asthma? Chest. 1988 Oct;94(4):718–722. doi: 10.1378/chest.94.4.718. [DOI] [PubMed] [Google Scholar]
  266. Hill M. R., Gotz V. P., Harman E., McLeod I., Hendeles L. Evaluation of the asthmogenicity of propafenone, a new antiarrhythmic drug. Comparison of spirometry with methacholine challenge. Chest. 1986 Nov;90(5):698–702. doi: 10.1378/chest.90.5.698. [DOI] [PubMed] [Google Scholar]
  267. Hiller E. J., Milner A. D. Betamethasone 17 valerate aerosol and disodium chromoglycate in severe childhood asthma. Br J Dis Chest. 1975 Apr;69(2):103–106. doi: 10.1016/s0007-0971(75)80026-x. [DOI] [PubMed] [Google Scholar]
  268. Hiltermann T. J., de Bruijne C. R., Stolk J., Zwinderman A. H., Spieksma F. T., Roemer W., Steerenberg P. A., Fischer P. H., van Bree L., Hiemstra P. S. Effects of photochemical air pollution and allergen exposure on upper respiratory tract inflammation in asthmatics. Am J Respir Crit Care Med. 1997 Dec;156(6):1765–1772. doi: 10.1164/ajrccm.156.6.9704127. [DOI] [PubMed] [Google Scholar]
  269. Hilton S., Sibbald B., Anderson H. R., Freeling P. Controlled evaluation of the effects of patient education on asthma morbidity in general practice. Lancet. 1986 Jan 4;1(8471):26–29. doi: 10.1016/s0140-6736(86)91904-5. [DOI] [PubMed] [Google Scholar]
  270. Hirsch T., Peter-Kern M., Koch R., Leupold W. Influence of inspiratory capacity on bronchodilatation via Turbuhaler or pressurized metered-dose inhaler in asthmatic children: a comparison. Respir Med. 1997 Jul;91(6):341–346. doi: 10.1016/s0954-6111(97)90060-3. [DOI] [PubMed] [Google Scholar]
  271. Holgate S. T. Clinical evaluation of nedocromil sodium in asthma. Br J Clin Pract Suppl. 1987 Nov;53:13–21. [PubMed] [Google Scholar]
  272. Holt P. G., O'Keeffe P., Holt B. J., Upham J. W., Baron-Hay M. J., Suphioglu C., Knox B., Stewart G. A., Thomas W. R., Sly P. D. T-cell "priming" against environmental allergens in human neonates: sequential deletion of food antigen reactivity during infancy with concomitant expansion of responses to ubiquitous inhalant allergens. Pediatr Allergy Immunol. 1995 May;6(2):85–90. doi: 10.1111/j.1399-3038.1995.tb00264.x. [DOI] [PubMed] [Google Scholar]
  273. Homer C. J., Szilagyi P., Rodewald L., Bloom S. R., Greenspan P., Yazdgerdi S., Leventhal J. M., Finkelstein D., Perrin J. M. Does quality of care affect rates of hospitalization for childhood asthma? Pediatrics. 1996 Jul;98(1):18–23. [PubMed] [Google Scholar]
  274. Horst M., Hejjaoui A., Horst V., Michel F. B., Bousquet J. Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract. J Allergy Clin Immunol. 1990 Feb;85(2):460–472. doi: 10.1016/0091-6749(90)90156-x. [DOI] [PubMed] [Google Scholar]
  275. Hoshino M., Nakamura Y., Shin Z., Fukushima Y. Effects of ketotifen on symptoms and on bronchial mucosa in patients with atopic asthma. Allergy. 1997 Aug;52(8):814–820. doi: 10.1111/j.1398-9995.1997.tb02152.x. [DOI] [PubMed] [Google Scholar]
  276. Howland J., Bauchner H., Adair R. The impact of pediatric asthma education on morbidity. Assessing the evidence. Chest. 1988 Nov;94(5):964–969. doi: 10.1378/chest.94.5.964. [DOI] [PubMed] [Google Scholar]
  277. Huang D., O'Brien R. G., Harman E., Aull L., Reents S., Visser J., Shieh G., Hendeles L. Does aminophylline benefit adults admitted to the hospital for an acute exacerbation of asthma? Ann Intern Med. 1993 Dec 15;119(12):1155–1160. doi: 10.7326/0003-4819-119-12-199312150-00001. [DOI] [PubMed] [Google Scholar]
  278. Hughes D. M., McLeod M., Garner B., Goldbloom R. B. Controlled trial of a home and ambulatory program for asthmatic children. Pediatrics. 1991 Jan;87(1):54–61. [PubMed] [Google Scholar]
  279. Hui K. P., Barnes N. C. Lung function improvement in asthma with a cysteinyl-leukotriene receptor antagonist. Lancet. 1991 May 4;337(8749):1062–1063. doi: 10.1016/0140-6736(91)91709-4. [DOI] [PubMed] [Google Scholar]
  280. Hunskaar S., Hannestad Y. S., Backe B., Matheson I. Direct mailing of consensus recommendations did not alter GPs' knowledge and prescription of oestrogen in the menopause. Scand J Prim Health Care. 1996 Dec;14(4):203–208. doi: 10.3109/02813439608997086. [DOI] [PubMed] [Google Scholar]
  281. Huss K., Squire E. N., Jr, Carpenter G. B., Smith L. J., Huss R. W., Salata K., Salerno M., Agostinelli D., Hershey J. Effective education of adults with asthma who are allergic to dust mites. J Allergy Clin Immunol. 1992 Apr;89(4):836–843. doi: 10.1016/0091-6749(92)90439-9. [DOI] [PubMed] [Google Scholar]
  282. Huss K., Squire E. N., Jr, Carpenter G. B., Smith L. J., Huss R. W., Salata K., Salerno M., Agostinelli D., Hershey J. Effective education of adults with asthma who are allergic to dust mites. J Allergy Clin Immunol. 1992 Apr;89(4):836–843. doi: 10.1016/0091-6749(92)90439-9. [DOI] [PubMed] [Google Scholar]
  283. Hyland M. E., Kenyon C. A., Allen R., Howarth P. Diary keeping in asthma: comparison of written and electronic methods. BMJ. 1993 Feb 20;306(6876):487–489. doi: 10.1136/bmj.306.6876.487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  284. Ichinose T., Takano H., Miyabara Y., Yanagisawa R., Sagai M. Murine strain differences in allergic airway inflammation and immunoglobulin production by a combination of antigen and diesel exhaust particles. Toxicology. 1997 Oct 19;122(3):183–192. doi: 10.1016/s0300-483x(97)00096-6. [DOI] [PubMed] [Google Scholar]
  285. Idris A. H., McDermott M. F., Raucci J. C., Morrabel A., McGorray S., Hendeles L. Emergency department treatment of severe asthma. Metered-dose inhaler plus holding chamber is equivalent in effectiveness to nebulizer. Chest. 1993 Mar;103(3):665–672. doi: 10.1378/chest.103.3.665. [DOI] [PubMed] [Google Scholar]
  286. Ignacio-Garcia J. M., Gonzalez-Santos P. Asthma self-management education program by home monitoring of peak expiratory flow. Am J Respir Crit Care Med. 1995 Feb;151(2 Pt 1):353–359. doi: 10.1164/ajrccm.151.2.7842191. [DOI] [PubMed] [Google Scholar]
  287. Infante-Rivard C. Childhood asthma and indoor environmental risk factors. Am J Epidemiol. 1993 Apr 15;137(8):834–844. doi: 10.1093/oxfordjournals.aje.a116745. [DOI] [PubMed] [Google Scholar]
  288. Inman M. D., O'Byrne P. M. The effect of regular inhaled albuterol on exercise-induced bronchoconstriction. Am J Respir Crit Care Med. 1996 Jan;153(1):65–69. doi: 10.1164/ajrccm.153.1.8542164. [DOI] [PubMed] [Google Scholar]
  289. Israel E., Cohn J., Dubé L., Drazen J. M. Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group. JAMA. 1996 Mar 27;275(12):931–936. [PubMed] [Google Scholar]
  290. Israel E., Fischer A. R., Rosenberg M. A., Lilly C. M., Callery J. C., Shapiro J., Cohn J., Rubin P., Drazen J. M. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am Rev Respir Dis. 1993 Dec;148(6 Pt 1):1447–1451. doi: 10.1164/ajrccm/148.6_Pt_1.1447. [DOI] [PubMed] [Google Scholar]
  291. Israel E., Rubin P., Kemp J. P., Grossman J., Pierson W., Siegel S. C., Tinkelman D., Murray J. J., Busse W., Segal A. T. The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma. Ann Intern Med. 1993 Dec 1;119(11):1059–1066. doi: 10.7326/0003-4819-119-11-199312010-00001. [DOI] [PubMed] [Google Scholar]
  292. Jakobsson T., Croner S., Kjellman N. I., Pettersson A., Vassella C., Björkstén B. Slight steroid-sparing effect of intravenous immunoglobulin in children and adolescents with moderately severe bronchial asthma. Allergy. 1994 Jul;49(6):413–420. doi: 10.1111/j.1398-9995.1994.tb00833.x. [DOI] [PubMed] [Google Scholar]
  293. Jasper A. C., Mohsenifar Z., Kahan S., Goldberg H. S., Koerner S. K. Cost-benefit comparison of aerosol bronchodilator delivery methods in hospitalized patients. Chest. 1987 Apr;91(4):614–618. doi: 10.1378/chest.91.4.614. [DOI] [PubMed] [Google Scholar]
  294. Jenkinson D., Davison J., Jones S., Hawtin P. Comparison of effects of a self management booklet and audiocassette for patients with asthma. BMJ. 1988 Jul 23;297(6643):267–270. doi: 10.1136/bmj.297.6643.267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  295. Jenne J. W. What role for theophylline? Thorax. 1994 Feb;49(2):97–100. doi: 10.1136/thx.49.2.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  296. Joe R. H., Kellermann A., Arheart K., Ellis R., Self T. Emergency department asthma treatment protocol. Ann Pharmacother. 1992 Apr;26(4):472–476. doi: 10.1177/106002809202600402. [DOI] [PubMed] [Google Scholar]
  297. Johnson M. A., Newman S. P., Bloom R., Talaee N., Clarke S. W. Delivery of albuterol and ipratropium bromide from two nebulizer systems in chronic stable asthma. Efficacy and pulmonary deposition. Chest. 1989 Jul;96(1):6–10. doi: 10.1378/chest.96.1.6. [DOI] [PubMed] [Google Scholar]
  298. Johnston R. G., Noseworthy T. W., Friesen E. G., Yule H. A., Shustack A. Isoflurane therapy for status asthmaticus in children and adults. Chest. 1990 Mar;97(3):698–701. doi: 10.1378/chest.97.3.698. [DOI] [PubMed] [Google Scholar]
  299. Johnston S. L. Influence of viral and bacterial respiratory infections on exacerbations and symptom severity in childhood asthma. Pediatr Pulmonol Suppl. 1997;16:88–89. doi: 10.1002/ppul.1950230851. [DOI] [PubMed] [Google Scholar]
  300. Jones F. L., Jr, Ekberg N. L. Exacerbation of asthma by timolol. N Engl J Med. 1979 Aug 2;301(5):270–270. [PubMed] [Google Scholar]
  301. Jones K. P., Mullee M. A., Middleton M., Chapman E., Holgate S. T. Peak flow based asthma self-management: a randomised controlled study in general practice. British Thoracic Society Research Committee. Thorax. 1995 Aug;50(8):851–857. doi: 10.1136/thx.50.8.851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  302. Jones T. R., Labelle M., Belley M., Champion E., Charette L., Evans J., Ford-Hutchinson A. W., Gauthier J. Y., Lord A., Masson P. Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist. Can J Physiol Pharmacol. 1995 Feb;73(2):191–201. doi: 10.1139/y95-028. [DOI] [PubMed] [Google Scholar]
  303. Jones T. R., Zamboni R., Belley M., Champion E., Charette L., Ford-Hutchinson A. W., Frenette R., Gauthier J. Y., Leger S., Masson P. Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist. Can J Physiol Pharmacol. 1989 Jan;67(1):17–28. doi: 10.1139/y89-004. [DOI] [PubMed] [Google Scholar]
  304. Juniper E. F., Daniel E. E., Roberts R. S., Kline P. A., Hargreave F. E., Newhouse M. T. Improvement in airway responsiveness and asthma severity during pregnancy. A prospective study. Am Rev Respir Dis. 1989 Oct;140(4):924–931. doi: 10.1164/ajrccm/140.4.924. [DOI] [PubMed] [Google Scholar]
  305. Juniper E. F., Guyatt G. H., Feeny D. H., Ferrie P. J., Griffith L. E., Townsend M. Measuring quality of life in children with asthma. Qual Life Res. 1996 Feb;5(1):35–46. doi: 10.1007/BF00435967. [DOI] [PubMed] [Google Scholar]
  306. Juniper E. F., Kline P. A., Vanzieleghem M. A., Ramsdale E. H., O'Byrne P. M., Hargreave F. E. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis. 1990 Oct;142(4):832–836. doi: 10.1164/ajrccm/142.4.832. [DOI] [PubMed] [Google Scholar]
  307. Jörres R., Nowak D., Magnussen H. The effect of ozone exposure on allergen responsiveness in subjects with asthma or rhinitis. Am J Respir Crit Care Med. 1996 Jan;153(1):56–64. doi: 10.1164/ajrccm.153.1.8542163. [DOI] [PubMed] [Google Scholar]
  308. Kanzow G., Nowak D., Magnussen H. Short term effect of methotrexate in severe steroid-dependent asthma. Lung. 1995;173(4):223–231. doi: 10.1007/BF00181874. [DOI] [PubMed] [Google Scholar]
  309. Karpel J. P., Schacter E. N., Fanta C., Levey D., Spiro P., Aldrich T., Menjoge S. S., Witek T. J. A comparison of ipratropium and albuterol vs albuterol alone for the treatment of acute asthma. Chest. 1996 Sep;110(3):611–616. doi: 10.1378/chest.110.3.611. [DOI] [PubMed] [Google Scholar]
  310. Kass J. E., Castriotta R. J. Heliox therapy in acute severe asthma. Chest. 1995 Mar;107(3):757–760. doi: 10.1378/chest.107.3.757. [DOI] [PubMed] [Google Scholar]
  311. Kelly H. W., Murphy S. Should we stop using theophylline for the treatment of the hospitalized patient with status asthmaticus? DICP. 1989 Dec;23(12):995–998. doi: 10.1177/106002808902301209. [DOI] [PubMed] [Google Scholar]
  312. Kemp J. P., Dockhorn R. J., Busse W. W., Bleecker E. R., Van As A. Prolonged effect of inhaled salmeterol against exercise-induced bronchospasm. Am J Respir Crit Care Med. 1994 Dec;150(6 Pt 1):1612–1615. doi: 10.1164/ajrccm.150.6.7952623. [DOI] [PubMed] [Google Scholar]
  313. Kendrick A. H., Higgs C. M., Whitfield M. J., Laszlo G. Accuracy of perception of severity of asthma: patients treated in general practice. BMJ. 1993 Aug 14;307(6901):422–424. doi: 10.1136/bmj.307.6901.422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  314. Kenyon C. J., Thorsson L., Borgström L., Newman S. P. The effects of static charge in spacer devices on glucocorticosteroid aerosol deposition in asthmatic patients. Eur Respir J. 1998 Mar;11(3):606–610. [PubMed] [Google Scholar]
  315. Kerem E., Canny G., Tibshirani R., Reisman J., Bentur L., Schuh S., Levison H. Clinical-physiologic correlations in acute asthma of childhood. Pediatrics. 1991 Apr;87(4):481–486. [PubMed] [Google Scholar]
  316. Kerstjens H. A., Brand P. L., de Jong P. M., Koëter G. H., Postma D. S. Influence of treatment on peak expiratory flow and its relation to airway hyperresponsiveness and symptoms. The Dutch CNSLD Study Group. Thorax. 1994 Nov;49(11):1109–1115. doi: 10.1136/thx.49.11.1109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  317. Kidney J., Dominguez M., Taylor P. M., Rose M., Chung K. F., Barnes P. J. Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy. Am J Respir Crit Care Med. 1995 Jun;151(6):1907–1914. doi: 10.1164/ajrccm.151.6.7767539. [DOI] [PubMed] [Google Scholar]
  318. Kikawa Y., Miyanomae T., Inoue Y., Saito M., Nakai A., Shigematsu Y., Hosoi S., Sudo M. Urinary leukotriene E4 after exercise challenge in children with asthma. J Allergy Clin Immunol. 1992 Jun;89(6):1111–1119. doi: 10.1016/0091-6749(92)90294-c. [DOI] [PubMed] [Google Scholar]
  319. Kisch G. L., Paloucek F. P. Metered-dose inhalers and nebulizers in the acute setting. Ann Pharmacother. 1992 Jan;26(1):92–95. doi: 10.1177/106002809202600116. [DOI] [PubMed] [Google Scholar]
  320. Klaustermeyer W. B., Noritake D. T., Kwong F. K. Chrysotherapy in the treatment of corticosteroid-dependent asthma. J Allergy Clin Immunol. 1987 May;79(5):720–725. doi: 10.1016/0091-6749(87)90202-8. [DOI] [PubMed] [Google Scholar]
  321. Kleijnen J., ter Riet G., Knipschild P. Acupuncture and asthma: a review of controlled trials. Thorax. 1991 Nov;46(11):799–802. doi: 10.1136/thx.46.11.799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  322. Klein R. B., Fritz G. K., Yeung A., McQuaid E. L., Mansell A. Spirometric patterns in childhood asthma: peak flow compared with other indices. Pediatr Pulmonol. 1995 Dec;20(6):372–379. doi: 10.1002/ppul.1950200607. [DOI] [PubMed] [Google Scholar]
  323. Kniest F. M., Young E., Van Praag M. C., Vos H., Kort H. S., Koers W. J., De Maat-Bleeker F., Van Bronswijk J. E. Clinical evaluation of a double-blind dust-mite avoidance trial with mite-allergic rhinitic patients. Clin Exp Allergy. 1991 Jan;21(1):39–47. doi: 10.1111/j.1365-2222.1991.tb00802.x. [DOI] [PubMed] [Google Scholar]
  324. Koenig J. Q., Covert D. S., Pierson W. E. Effects of inhalation of acidic compounds on pulmonary function in allergic adolescent subjects. Environ Health Perspect. 1989 Feb;79:173–178. doi: 10.1289/ehp.8979173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  325. Koenig J. Q., Larson T. V., Hanley Q. S., Rebolledo V., Dumler K., Checkoway H., Wang S. Z., Lin D., Pierson W. E. Pulmonary function changes in children associated with fine particulate matter. Environ Res. 1993 Oct;63(1):26–38. doi: 10.1006/enrs.1993.1123. [DOI] [PubMed] [Google Scholar]
  326. Kogevinas M., Antó J. M., Soriano J. B., Tobias A., Burney P. The risk of asthma attributable to occupational exposures. A population-based study in Spain. Spanish Group of the European Asthma Study. Am J Respir Crit Care Med. 1996 Jul;154(1):137–143. doi: 10.1164/ajrccm.154.1.8680669. [DOI] [PubMed] [Google Scholar]
  327. Korsgaard J. Preventive measures in house-dust allergy. Am Rev Respir Dis. 1982 Jan;125(1):80–84. doi: 10.1164/arrd.1982.125.1.80. [DOI] [PubMed] [Google Scholar]
  328. Kotses H., Stout C., McConnaughy K., Winder J. A., Creer T. L. Evaluation of individualized asthma self-management programs. J Asthma. 1996;33(2):113–118. doi: 10.3109/02770909609054539. [DOI] [PubMed] [Google Scholar]
  329. Kotses H., Stout C., Wigal J. K., Carlson B., Creer T. L., Lewis P. Individualized asthma self-management: a beginning. J Asthma. 1991;28(4):287–289. doi: 10.3109/02770909109073386. [DOI] [PubMed] [Google Scholar]
  330. Kraemer R., Frey U., Sommer C. W., Russi E. Short-term effect of albuterol, delivered via a new auxiliary device, in wheezy infants. Am Rev Respir Dis. 1991 Aug;144(2):347–351. doi: 10.1164/ajrccm/144.2.347. [DOI] [PubMed] [Google Scholar]
  331. Kraft M., Torvik J. A., Trudeau J. B., Wenzel S. E., Martin R. J. Theophylline: potential antiinflammatory effects in nocturnal asthma. J Allergy Clin Immunol. 1996 Jun;97(6):1242–1246. doi: 10.1016/s0091-6749(96)70191-4. [DOI] [PubMed] [Google Scholar]
  332. Kreisman H., Frank H., Wolkove N., Gent M. Synergism between ipratropium and theophylline in asthma. Thorax. 1981 May;36(5):387–391. doi: 10.1136/thx.36.5.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  333. König P., Eigen H., Ellis M. H., Ellis E., Blake K., Geller D., Shapiro G., Welch M., Scott C. The effect of nedocromil sodium on childhood asthma during the viral season. Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):1879–1886. doi: 10.1164/ajrccm.152.6.8520750. [DOI] [PubMed] [Google Scholar]
  334. L'Hommedieu C. S., Arens J. J. The use of ketamine for the emergency intubation of patients with status asthmaticus. Ann Emerg Med. 1987 May;16(5):568–571. doi: 10.1016/s0196-0644(87)80688-1. [DOI] [PubMed] [Google Scholar]
  335. Laberge S., Spier S., Drblik S. P., Turgeon J. P. Comparison of inhaled terbutaline administered by either the Turbuhaler dry powder inhaler or a metered-dose inhaler with spacer in preschool children with asthma. J Pediatr. 1994 May;124(5 Pt 1):815–817. doi: 10.1016/s0022-3476(05)81381-2. [DOI] [PubMed] [Google Scholar]
  336. Lahdensuo A., Haahtela T., Herrala J., Kava T., Kiviranta K., Kuusisto P., Perämäki E., Poussa T., Saarelainen S., Svahn T. Randomised comparison of guided self management and traditional treatment of asthma over one year. BMJ. 1996 Mar 23;312(7033):748–752. doi: 10.1136/bmj.312.7033.748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  337. Laitinen L. A., Laitinen A., Haahtela T. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol. 1992 Jul;90(1):32–42. doi: 10.1016/s0091-6749(06)80008-4. [DOI] [PubMed] [Google Scholar]
  338. Lanes S. F., Garrett J. E., Wentworth C. E., 3rd, Fitzgerald J. M., Karpel J. P. The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials. Chest. 1998 Aug;114(2):365–372. doi: 10.1378/chest.114.2.365. [DOI] [PubMed] [Google Scholar]
  339. Lawford P., Jones B. J., Milledge J. S. Comparison of intravenous and nebulised salbutamol in initial treatment of severe asthma. Br Med J. 1978 Jan 14;1(6105):84–84. doi: 10.1136/bmj.1.6105.84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  340. Lee H., Evans H. E. Evaluation of inhalation aids of metered dose inhalers in asthmatic children. Chest. 1987 Mar;91(3):366–369. doi: 10.1378/chest.91.3.366. [DOI] [PubMed] [Google Scholar]
  341. Lefcoe N. M., Toogood J. H., Blennerhassett G., Baskerville J., Paterson N. A. The addition of an aerosol anticholinergic to an oral beta agonist plus theophylline in asthma and bronchitis. A double-blind single dose study. Chest. 1982 Sep;82(3):300–305. doi: 10.1378/chest.82.3.300. [DOI] [PubMed] [Google Scholar]
  342. Legorreta A. P., Christian-Herman J., O'Connor R. D., Hasan M. M., Evans R., Leung K. M. Compliance with national asthma management guidelines and specialty care: a health maintenance organization experience. Arch Intern Med. 1998 Mar 9;158(5):457–464. doi: 10.1001/archinte.158.5.457. [DOI] [PubMed] [Google Scholar]
  343. Leung D. Y., Szefler S. J. Diagnosis and management of steroid-resistant asthma. Clin Chest Med. 1997 Sep;18(3):611–625. doi: 10.1016/s0272-5231(05)70405-6. [DOI] [PubMed] [Google Scholar]
  344. Lewis C. E., Rachelefsky G., Lewis M. A., de la Sota A., Kaplan M. A randomized trial of A.C.T. (asthma care training) for kids. Pediatrics. 1984 Oct;74(4):478–486. [PubMed] [Google Scholar]
  345. Lieu T. A., Quesenberry C. P., Jr, Capra A. M., Sorel M. E., Martin K. E., Mendoza G. R. Outpatient management practices associated with reduced risk of pediatric asthma hospitalization and emergency department visits. Pediatrics. 1997 Sep;100(3 Pt 1):334–341. doi: 10.1542/peds.100.3.334. [DOI] [PubMed] [Google Scholar]
  346. Lilja G., Sundin B., Graff-Lonnevig V., Hedlin G., Heilborn H., Norrlind K., Pegelow K. O., Løwenstein H. Immunotherapy with cat- and dog-dander extracts. IV. Effects of 2 years of treatment. J Allergy Clin Immunol. 1989 Jan;83(1):37–44. doi: 10.1016/0091-6749(89)90475-2. [DOI] [PubMed] [Google Scholar]
  347. Lin R. Y., Pesola G. R., Bakalchuk L., Morgan J. P., Heyl G. T., Freyberg C. W., Cataquet D., Westfal R. E. Superiority of ipratropium plus albuterol over albuterol alone in the emergency department management of adult asthma: a randomized clinical trial. Ann Emerg Med. 1998 Feb;31(2):208–213. doi: 10.1016/s0196-0644(98)70308-7. [DOI] [PubMed] [Google Scholar]
  348. Lindgren S., Lokshin B., Stromquist A., Weinberger M., Nassif E., McCubbin M., Frasher R. Does asthma or treatment with theophylline limit children's academic performance? N Engl J Med. 1992 Sep 24;327(13):926–930. doi: 10.1056/NEJM199209243271305. [DOI] [PubMed] [Google Scholar]
  349. Lindén A., Rabe K. F., Löfdahl C. G. Pharmacological basis for duration of effect: formoterol and salmeterol versus short-acting beta 2-adrenoceptor agonists. Lung. 1996;174(1):1–22. doi: 10.1007/BF00167947. [DOI] [PubMed] [Google Scholar]
  350. Linn W. S., Avol E. L., Shamoo D. A., Whynot J. D., Anderson K. R., Hackney J. D. Respiratory responses of exercising asthmatic volunteers exposed to sulfuric acid aerosol. J Air Pollut Control Assoc. 1986 Dec;36(12):1323–1328. doi: 10.1080/00022470.1986.10466181. [DOI] [PubMed] [Google Scholar]
  351. Litonjua A. A., Sparrow D., Weiss S. T., O'Connor G. T., Long A. A., Ohman J. L., Jr Sensitization to cat allergen is associated with asthma in older men and predicts new-onset airway hyperresponsiveness. The Normative Aging Study. Am J Respir Crit Care Med. 1997 Jul;156(1):23–27. doi: 10.1164/ajrccm.156.1.9608072. [DOI] [PubMed] [Google Scholar]
  352. Littenberg B. Aminophylline treatment in severe, acute asthma. A meta-analysis. JAMA. 1988 Mar 18;259(11):1678–1684. [PubMed] [Google Scholar]
  353. Liu M. C., Dubé L. M., Lancaster J. Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group. J Allergy Clin Immunol. 1996 Nov;98(5 Pt 1):859–871. doi: 10.1016/s0091-6749(96)80002-9. [DOI] [PubMed] [Google Scholar]
  354. Lock S. H., Kay A. B., Barnes N. C. Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma. Am J Respir Crit Care Med. 1996 Feb;153(2):509–514. doi: 10.1164/ajrccm.153.2.8564089. [DOI] [PubMed] [Google Scholar]
  355. Lockey R. F., Benedict L. M., Turkeltaub P. C., Bukantz S. C. Fatalities from immunotherapy (IT) and skin testing (ST) J Allergy Clin Immunol. 1987 Apr;79(4):660–677. doi: 10.1016/s0091-6749(87)80164-1. [DOI] [PubMed] [Google Scholar]
  356. Lombardi E., Morgan W. J., Wright A. L., Stein R. T., Holberg C. J., Martinez F. D. Cold air challenge at age 6 and subsequent incidence of asthma. A longitudinal study. Am J Respir Crit Care Med. 1997 Dec;156(6):1863–1869. doi: 10.1164/ajrccm.156.6.9612066. [DOI] [PubMed] [Google Scholar]
  357. Lowell F. C., Franklin W. A double-blind study of the effectiveness and specificity of injecton therapy in ragweed hay fever. N Engl J Med. 1965 Sep 23;273(13):675–679. doi: 10.1056/NEJM196509232731302. [DOI] [PubMed] [Google Scholar]
  358. Löwhagen O., Rak S. Modification of bronchial hyperreactivity after treatment with sodium cromoglycate during pollen season. J Allergy Clin Immunol. 1985 Apr;75(4):460–467. doi: 10.1016/s0091-6749(85)80018-x. [DOI] [PubMed] [Google Scholar]
  359. Løvik M., Høgseth A. K., Gaarder P. I., Hagemann R., Eide I. Diesel exhaust particles and carbon black have adjuvant activity on the local lymph node response and systemic IgE production to ovalbumin. Toxicology. 1997 Aug 15;121(2):165–178. doi: 10.1016/s0300-483x(97)00075-9. [DOI] [PubMed] [Google Scholar]
  360. Magnussen H., Nowak D., Wiebicke W. Effect of inhaled ipratropium bromide on the airway response to methacholine, histamine, and exercise in patients with mild bronchial asthma. Respiration. 1992;59(1):42–47. doi: 10.1159/000196023. [DOI] [PubMed] [Google Scholar]
  361. Mak V. H., Melchor R., Spiro S. G. Easy bruising as a side-effect of inhaled corticosteroids. Eur Respir J. 1992 Oct;5(9):1068–1074. [PubMed] [Google Scholar]
  362. Malo J. L., Ghezzo H., L'Archevêque J., Lagier F., Perrin B., Cartier A. Is the clinical history a satisfactory means of diagnosing occupational asthma? Am Rev Respir Dis. 1991 Mar;143(3):528–532. doi: 10.1164/ajrccm/143.3.528. [DOI] [PubMed] [Google Scholar]
  363. Malo J. L., L'Archevêque J., Trudeau C., d'Aquino C., Cartier A. Should we monitor peak expiratory flow rates or record symptoms with a simple diary in the management of asthma? J Allergy Clin Immunol. 1993 Mar;91(3):702–709. doi: 10.1016/0091-6749(93)90189-m. [DOI] [PubMed] [Google Scholar]
  364. Mann R. D., Kubota K., Pearce G., Wilton L. Salmeterol: a study by prescription-event monitoring in a UK cohort of 15,407 patients. J Clin Epidemiol. 1996 Feb;49(2):247–250. doi: 10.1016/0895-4356(95)00555-2. [DOI] [PubMed] [Google Scholar]
  365. Manning P. J., Rokach J., Malo J. L., Ethier D., Cartier A., Girard Y., Charleson S., O'Byrne P. M. Urinary leukotriene E4 levels during early and late asthmatic responses. J Allergy Clin Immunol. 1990 Aug;86(2):211–220. doi: 10.1016/s0091-6749(05)80068-5. [DOI] [PubMed] [Google Scholar]
  366. Manning P. J., Watson R. M., Margolskee D. J., Williams V. C., Schwartz J. I., O'Byrne P. M. Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist. N Engl J Med. 1990 Dec 20;323(25):1736–1739. doi: 10.1056/NEJM199012203232504. [DOI] [PubMed] [Google Scholar]
  367. Manolitsas N. D., Wang J., Devalia J. L., Trigg C. J., McAulay A. E., Davies R. J. Regular albuterol, nedocromil sodium, and bronchial inflammation in asthma. Am J Respir Crit Care Med. 1995 Jun;151(6):1925–1930. doi: 10.1164/ajrccm.151.6.7767541. [DOI] [PubMed] [Google Scholar]
  368. Marin J. M., Carrizo S. J., Garcia R., Ejea M. V. Effects of nedocromil sodium in steroid-resistant asthma: a randomized controlled trial. J Allergy Clin Immunol. 1996 Feb;97(2):602–610. doi: 10.1016/s0091-6749(96)70305-6. [DOI] [PubMed] [Google Scholar]
  369. Marin M. G. Low-dose methotrexate spares steroid usage in steroid-dependent asthmatic patients: a meta-analysis. Chest. 1997 Jul;112(1):29–33. doi: 10.1378/chest.112.1.29. [DOI] [PubMed] [Google Scholar]
  370. Marom Z., Shelhamer J. H., Bach M. K., Morton D. R., Kaliner M. Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro. Am Rev Respir Dis. 1982 Sep;126(3):449–451. doi: 10.1164/arrd.1982.126.3.449. [DOI] [PubMed] [Google Scholar]
  371. Marone G., Columbo M., Galeone D., Guidi G., Kagey-Sobotka A., Lichtenstein L. M. Modulation of the release of histamine and arachidonic acid metabolites from human basophils and mast cells by auranofin. Agents Actions. 1986 Apr;18(1-2):100–102. doi: 10.1007/BF01987994. [DOI] [PubMed] [Google Scholar]
  372. Martinez F. D., Cline M., Burrows B. Increased incidence of asthma in children of smoking mothers. Pediatrics. 1992 Jan;89(1):21–26. [PubMed] [Google Scholar]
  373. Martinez F. D. Definition of pediatric asthma and associated risk factors. Pediatr Pulmonol Suppl. 1997 Sep;15:9–12. [PubMed] [Google Scholar]
  374. Martinez F. D., Wright A. L., Taussig L. M., Holberg C. J., Halonen M., Morgan W. J. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med. 1995 Jan 19;332(3):133–138. doi: 10.1056/NEJM199501193320301. [DOI] [PubMed] [Google Scholar]
  375. Maynard A. Evidence-based medicine: an incomplete method for informing treatment choices. Lancet. 1997 Jan 11;349(9045):126–128. doi: 10.1016/S0140-6736(96)05153-7. [DOI] [PubMed] [Google Scholar]
  376. Mayo P. H., Richman J., Harris H. W. Results of a program to reduce admissions for adult asthma. Ann Intern Med. 1990 Jun 1;112(11):864–871. doi: 10.7326/0003-4819-112-11-864. [DOI] [PubMed] [Google Scholar]
  377. Mayo P. H., Richman J., Harris H. W. Results of a program to reduce admissions for adult asthma. Ann Intern Med. 1990 Jun 1;112(11):864–871. doi: 10.7326/0003-4819-112-11-864. [DOI] [PubMed] [Google Scholar]
  378. Mazer B. D., Gelfand E. W. An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma. J Allergy Clin Immunol. 1991 May;87(5):976–983. doi: 10.1016/0091-6749(91)90420-s. [DOI] [PubMed] [Google Scholar]
  379. McFadden E. R., Jr Critical appraisal of the therapy of asthma--an idea whose time has come. Am Rev Respir Dis. 1986 May;133(5):723–724. doi: 10.1164/arrd.1986.133.5.723. [DOI] [PubMed] [Google Scholar]
  380. McFadden E. R., Jr Dosages of corticosteroids in asthma. Am Rev Respir Dis. 1993 May;147(5):1306–1310. doi: 10.1164/ajrccm/147.5.1306. [DOI] [PubMed] [Google Scholar]
  381. McNabb W. L., Wilson-Pessano S. R., Hughes G. W., Scamagas P. Self-management education of children with asthma: AIR WISE. Am J Public Health. 1985 Oct;75(10):1219–1220. doi: 10.2105/ajph.75.10.1219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  382. Mcivor R. A., Pizzichini E., Turner M. O., Hussack P., Hargreave F. E., Sears M. R. Potential masking effects of salmeterol on airway inflammation in asthma. Am J Respir Crit Care Med. 1998 Sep;158(3):924–930. doi: 10.1164/ajrccm.158.3.9802069. [DOI] [PubMed] [Google Scholar]
  383. Melchor R., Biddiscombe M. F., Mak V. H., Short M. D., Spiro S. G. Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction. Thorax. 1993 May;48(5):506–511. doi: 10.1136/thx.48.5.506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  384. Menitove S. M., Goldring R. M. Combined ventilator and bicarbonate strategy in the management of status asthmaticus. Am J Med. 1983 May;74(5):898–901. doi: 10.1016/0002-9343(83)91082-3. [DOI] [PubMed] [Google Scholar]
  385. Meredith S., Nordman H. Occupational asthma: measures of frequency from four countries. Thorax. 1996 Apr;51(4):435–440. doi: 10.1136/thx.51.4.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  386. Miles J. F., Bright P., Ayres J. G., Cayton R. M., Miller M. R. The performance of Mini Wright peak flow meters after prolonged use. Respir Med. 1995 Oct;89(9):603–605. doi: 10.1016/0954-6111(95)90227-9. [DOI] [PubMed] [Google Scholar]
  387. Mitchell I., Paterson I. C., Cameron S. J., Grant I. W. Treatment of childhood asthma with sodium cromoglycate and beclomethasone dipropionate aerosol singly and in combination. Br Med J. 1976 Aug 21;2(6033):457–458. doi: 10.1136/bmj.2.6033.457-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  388. Mitenko P. A., Ogilvie R. I. Rational intravenous doses of theophylline. N Engl J Med. 1973 Sep 20;289(12):600–603. doi: 10.1056/NEJM197309202891202. [DOI] [PubMed] [Google Scholar]
  389. Moldofsky H., Broder I., Davies G., Leznoff A. Videotape educational program for people with asthma. Can Med Assoc J. 1979 Mar 17;120(6):669–672. [PMC free article] [PubMed] [Google Scholar]
  390. Molema J., van Herwaarden C. L., Folgering H. T. Effects of long-term treatment with inhaled cromoglycate and budesonide on bronchial hyperresponsiveness in patients with allergic asthma. Eur Respir J. 1989 Apr;2(4):308–316. [PubMed] [Google Scholar]
  391. Molfino N. A., Wright S. C., Katz I., Tarlo S., Silverman F., McClean P. A., Szalai J. P., Raizenne M., Slutsky A. S., Zamel N. Effect of low concentrations of ozone on inhaled allergen responses in asthmatic subjects. Lancet. 1991 Jul 27;338(8761):199–203. doi: 10.1016/0140-6736(91)90346-q. [DOI] [PubMed] [Google Scholar]
  392. Muir J. F., Bertin L., Georges D. Salmeterol versus slow-release theophylline combined with ketotifen in nocturnal asthma: a multicentre trial. French Multicentre Study Group. Eur Respir J. 1992 Nov;5(10):1197–1200. [PubMed] [Google Scholar]
  393. Mukhopadhyay S., Staddon G. E., Eastman C., Palmer M., Davies E. R., Carswell F. The quantitative distribution of nebulized antibiotic in the lung in cystic fibrosis. Respir Med. 1994 Mar;88(3):203–211. doi: 10.1016/s0954-6111(05)80348-8. [DOI] [PubMed] [Google Scholar]
  394. Mulloy E., Donaghy D., Quigley C., McNicholas W. T. A one-year prospective audit of an asthma education programme in an out-patient setting. Ir Med J. 1996 Nov-Dec;89(6):226–228. [PubMed] [Google Scholar]
  395. Munir A. K., Kjellman N. I., Björkstén B. Exposure to indoor allergens in early infancy and sensitization. J Allergy Clin Immunol. 1997 Aug;100(2):177–181. doi: 10.1016/s0091-6749(97)70221-5. [DOI] [PubMed] [Google Scholar]
  396. Muranaka M., Miyamoto T., Shida T., Kabe J., Makino S., Okumura H., Takeda K., Suzuki S., Horiuchi Y. Gold salt in the treatment of bronchial asthma--a double-blind study. Ann Allergy. 1978 Feb;40(2):132–137. [PubMed] [Google Scholar]
  397. Murray A. B., Ferguson A. C. Dust-free bedrooms in the treatment of asthmatic children with house dust or house dust mite allergy: a controlled trial. Pediatrics. 1983 Mar;71(3):418–422. [PubMed] [Google Scholar]
  398. Murray A. B., Morrison B. J. The decrease in severity of asthma in children of parents who smoke since the parents have been exposing them to less cigarette smoke. J Allergy Clin Immunol. 1993 Jan;91(1 Pt 1):102–110. doi: 10.1016/0091-6749(93)90302-v. [DOI] [PubMed] [Google Scholar]
  399. Murray A. B., Morrison B. J. The effect of cigarette smoke from the mother on bronchial responsiveness and severity of symptoms in children with asthma. J Allergy Clin Immunol. 1986 Apr;77(4):575–581. doi: 10.1016/0091-6749(86)90348-9. [DOI] [PubMed] [Google Scholar]
  400. Mylona-Karayanni C., Hadziargurou D., Liapi-Adamidou G., Anagnostakis I., Sinaniotis C., Saxoni-Papageorgiou F. Effect of ketotifen on childhood asthma: a double-blind study. J Asthma. 1990;27(2):87–93. doi: 10.3109/02770909009073302. [DOI] [PubMed] [Google Scholar]
  401. Nana A., Youngchaiyud P., Maranetra N., Boe J., Löfdahl C. G., Selroos O., Ståhl E. Beta 2-agonists administered by a dry powder inhaler can be used in acute asthma. Respir Med. 1998 Feb;92(2):167–172. doi: 10.1016/s0954-6111(98)90090-7. [DOI] [PubMed] [Google Scholar]
  402. Nassif E. G., Weinberger M., Thompson R., Huntley W. The value of maintenance theophylline in steroid-dependent asthma. N Engl J Med. 1981 Jan 8;304(2):71–75. doi: 10.1056/NEJM198101083040202. [DOI] [PubMed] [Google Scholar]
  403. Nelson H. S., Spector S. L., Whitsett T. L., George R. B., Dwek J. H. The bronchodilator response to inhalation of increasing doses of aerosolized albuterol. J Allergy Clin Immunol. 1983 Oct;72(4):371–375. doi: 10.1016/0091-6749(83)90502-x. [DOI] [PubMed] [Google Scholar]
  404. Nelson R. P., Jr, DiNicolo R., Fernández-Caldas E., Seleznick M. J., Lockey R. F., Good R. A. Allergen-specific IgE levels and mite allergen exposure in children with acute asthma first seen in an emergency department and in nonasthmatic control subjects. J Allergy Clin Immunol. 1996 Aug;98(2):258–263. doi: 10.1016/s0091-6749(96)70148-3. [DOI] [PubMed] [Google Scholar]
  405. Newhouse M. T., Dolovich M. B. Control of asthma by aerosols. N Engl J Med. 1986 Oct 2;315(14):870–874. doi: 10.1056/NEJM198610023151406. [DOI] [PubMed] [Google Scholar]
  406. Newman S. P., Millar A. B., Lennard-Jones T. R., Morén F., Clarke S. W. Improvement of pressurised aerosol deposition with Nebuhaler spacer device. Thorax. 1984 Dec;39(12):935–941. doi: 10.1136/thx.39.12.935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  407. Newman S. P., Pavia D., Morén F., Sheahan N. F., Clarke S. W. Deposition of pressurised aerosols in the human respiratory tract. Thorax. 1981 Jan;36(1):52–55. doi: 10.1136/thx.36.1.52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  408. Newman S. P., Weisz A. W., Talaee N., Clarke S. W. Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. Thorax. 1991 Oct;46(10):712–716. doi: 10.1136/thx.46.10.712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  409. Nielsen N. H., Bronfort G., Bendix T., Madsen F., Weeke B. Chronic asthma and chiropractic spinal manipulation: a randomized clinical trial. Clin Exp Allergy. 1995 Jan;25(1):80–88. doi: 10.1111/j.1365-2222.1995.tb01006.x. [DOI] [PubMed] [Google Scholar]
  410. Nierop G., Gijzel W. P., Bel E. H., Zwinderman A. H., Dijkman J. H. Auranofin in the treatment of steroid dependent asthma: a double blind study. Thorax. 1992 May;47(5):349–354. doi: 10.1136/thx.47.5.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  411. Nilsen A., Hagemann R., Eide I. The adjuvant activity of diesel exhaust particles and carbon black on systemic IgE production to ovalbumin in mice after intranasal instillation. Toxicology. 1997 Dec 31;124(3):225–232. doi: 10.1016/s0300-483x(97)00150-9. [DOI] [PubMed] [Google Scholar]
  412. Nizankowska E., Soja J., Pinis G., Bochenek G., Sładek K., Domagała B., Pajak A., Szczeklik A. Treatment of steroid-dependent bronchial asthma with cyclosporin. Eur Respir J. 1995 Jul;8(7):1091–1099. doi: 10.1183/09031936.95.08071091. [DOI] [PubMed] [Google Scholar]
  413. Norman P. S. Is there a role for immunotherapy in the treatment of asthma? Yes. Am J Respir Crit Care Med. 1996 Nov;154(5):1225–1226. doi: 10.1164/ajrccm.154.5.8912729. [DOI] [PubMed] [Google Scholar]
  414. Norman P. S., Winkenwerder W. L., Lichtenstein L. M. Immunotherapy of hay fever with ragweed antigen E: comparisons with whole pollen extract and placebos. J Allergy. 1968 Aug;42(2):93–108. doi: 10.1016/0021-8707(68)90139-1. [DOI] [PubMed] [Google Scholar]
  415. Nowak R. M., Gordon K. R., Wroblewski D. A., Tomlanovich M. C., Kvale P. A. Spirometric evaluation of acute bronchial asthma. JACEP. 1979 Jan;8(1):9–12. doi: 10.1016/s0361-1124(79)80439-6. [DOI] [PubMed] [Google Scholar]
  416. Nowak R. M., Pensler M. I., Sarkar D. D., Anderson J. A., Kvale P. A., Ortiz A. E., Tomlanovich M. C. Comparison of peak expiratory flow and FEV1 admission criteria for acute bronchial asthma. Ann Emerg Med. 1982 Feb;11(2):64–69. doi: 10.1016/s0196-0644(82)80298-9. [DOI] [PubMed] [Google Scholar]
  417. O'Callaghan C., Cant M., Robertson C. Delivery of beclomethasone dipropionate from a spacer device: what dose is available for inhalation? Thorax. 1994 Oct;49(10):961–964. doi: 10.1136/thx.49.10.961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  418. O'Callaghan C., Lynch J., Cant M., Robertson C. Improvement in sodium cromoglycate delivery from a spacer device by use of an antistatic lining, immediate inhalation, and avoiding multiple actuations of drug. Thorax. 1993 Jun;48(6):603–606. doi: 10.1136/thx.48.6.603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  419. O'Doherty M. J., Thomas S. H., Gibb D., Page C. J., Harrington C., Duggan C., Nunan T. O., Bateman N. T. Lung deposition of nebulised pentamidine in children. Thorax. 1993 Mar;48(3):220–226. doi: 10.1136/thx.48.3.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  420. O'Donohue W. J., Jr Guidelines for the use of nebulizers in the home and at domiciliary sites. Report of a consensus conference. National Association for Medical Direction of Respiratory Care (NAMDRC) Consensus Group. Chest. 1996 Mar;109(3):814–820. doi: 10.1378/chest.109.3.814. [DOI] [PubMed] [Google Scholar]
  421. O'Driscoll B. R., Kalra S., Wilson M., Pickering C. A., Carroll K. B., Woodcock A. A. Double-blind trial of steroid tapering in acute asthma. Lancet. 1993 Feb 6;341(8841):324–327. doi: 10.1016/0140-6736(93)90134-3. [DOI] [PubMed] [Google Scholar]
  422. O'Driscoll B. R., Taylor R. J., Horsley M. G., Chambers D. K., Bernstein A. Nebulised salbutamol with and without ipratropium bromide in acute airflow obstruction. Lancet. 1989 Jun 24;1(8652):1418–1420. doi: 10.1016/s0140-6736(89)90126-8. [DOI] [PubMed] [Google Scholar]
  423. O'Hickey S. P., Rees P. J. High-dose nedocromil sodium as an addition to inhaled corticosteroids in the treatment of asthma. Respir Med. 1994 Aug;88(7):499–502. doi: 10.1016/s0954-6111(05)80330-0. [DOI] [PubMed] [Google Scholar]
  424. O'Hollaren M. T., Yunginger J. W., Offord K. P., Somers M. J., O'Connell E. J., Ballard D. J., Sachs M. I. Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med. 1991 Feb 7;324(6):359–363. doi: 10.1056/NEJM199102073240602. [DOI] [PubMed] [Google Scholar]
  425. O'Rourke P. P., Crone R. K. Halothane in status asthmaticus. Crit Care Med. 1982 May;10(5):341–343. doi: 10.1097/00003246-198205000-00013. [DOI] [PubMed] [Google Scholar]
  426. Ohman J. L., Jr, Findlay S. R., Leitermann K. M. Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of in vivo and in vitro responses. J Allergy Clin Immunol. 1984 Sep;74(3 Pt 1):230–239. doi: 10.1016/0091-6749(84)90251-3. [DOI] [PubMed] [Google Scholar]
  427. Ortiz Aldana I., Arreguín Osuna L., García Caballero R. Saturación arterial de oxígeno contra flujo espiratorio máximo como valores predictivos en la evolución de la crisis asmática en niños. Rev Alerg Mex. 1997 Nov-Dec;44(6):158–161. [PubMed] [Google Scholar]
  428. Osman L. M., Abdalla M. I., Beattie J. A., Ross S. J., Russell I. T., Friend J. A., Legge J. S., Douglas J. G. Reducing hospital admission through computer supported education for asthma patients. Grampian Asthma Study of Integrated Care (GRASSIC). BMJ. 1994 Feb 26;308(6928):568–571. doi: 10.1136/bmj.308.6928.568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  429. Osmond M. H., Klassen T. P. Efficacy of ipratropium bromide in acute childhood asthma: a meta-analysis. Acad Emerg Med. 1995 Jul;2(7):651–656. doi: 10.1111/j.1553-2712.1995.tb03607.x. [DOI] [PubMed] [Google Scholar]
  430. Ostro B. D., Lipsett M. J., Mann J. K., Krupnick A., Harrington W. Air pollution and respiratory morbidity among adults in southern California. Am J Epidemiol. 1993 Apr 1;137(7):691–700. doi: 10.1093/oxfordjournals.aje.a116729. [DOI] [PubMed] [Google Scholar]
  431. Ostro B. D., Lipsett M. J., Wiener M. B., Selner J. C. Asthmatic responses to airborne acid aerosols. Am J Public Health. 1991 Jun;81(6):694–702. doi: 10.2105/ajph.81.6.694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  432. Oxman A. D., Thomson M. A., Davis D. A., Haynes R. B. No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. CMAJ. 1995 Nov 15;153(10):1423–1431. [PMC free article] [PubMed] [Google Scholar]
  433. Paggiaro P. L., Giannini D., Di Franco A., Testi R. Comparison of inhaled salmeterol and individually dose-titrated slow-release theophylline in patients with reversible airway obstruction. European Study Group. Eur Respir J. 1996 Aug;9(8):1689–1695. doi: 10.1183/09031936.96.09081689. [DOI] [PubMed] [Google Scholar]
  434. Pakes G. E., Brogden R. N., Heel R. C., Speight T. M., Avery G. S. Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis. Drugs. 1980 Oct;20(4):237–266. doi: 10.2165/00003495-198020040-00001. [DOI] [PubMed] [Google Scholar]
  435. Papo M. C., Frank J., Thompson A. E. A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children. Crit Care Med. 1993 Oct;21(10):1479–1486. doi: 10.1097/00003246-199310000-00015. [DOI] [PubMed] [Google Scholar]
  436. Parameswaran K., Hildreth A. J., Chadha D., Keaney N. P., Taylor I. K., Bansal S. K. Asthma in the elderly: underperceived, underdiagnosed and undertreated; a community survey. Respir Med. 1998 Mar;92(3):573–577. doi: 10.1016/s0954-6111(98)90311-0. [DOI] [PubMed] [Google Scholar]
  437. Partridge M. R. Delivering optimal care to the person with asthma: what are the key components and what do we mean by patient education? Eur Respir J. 1995 Feb;8(2):298–305. doi: 10.1183/09031936.95.08020298. [DOI] [PubMed] [Google Scholar]
  438. Patel K. R., Kerr J. W. The dose-duration effect of sodium cromoglycate in exercise-induced asthma. Clin Allergy. 1984 Jan;14(1):87–91. doi: 10.1111/j.1365-2222.1984.tb02195.x. [DOI] [PubMed] [Google Scholar]
  439. Patterson R. Clinical efficacy of allergen immunotherapy. J Allergy Clin Immunol. 1979 Sep;64(3):155–158. doi: 10.1016/0091-6749(79)90089-7. [DOI] [PubMed] [Google Scholar]
  440. Pauwels R. A., Löfdahl C. G., Postma D. S., Tattersfield A. E., O'Byrne P., Barnes P. J., Ullman A. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med. 1997 Nov 13;337(20):1405–1411. doi: 10.1056/NEJM199711133372001. [DOI] [PubMed] [Google Scholar]
  441. Pauwels R. A., Yernault J. C., Demedts M. G., Geusens P. Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group. Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):827–832. doi: 10.1164/ajrccm.157.3.9610009. [DOI] [PubMed] [Google Scholar]
  442. Peat J. K., Britton W. J., Salome C. M., Woolcock A. J. Bronchial hyperresponsiveness in two populations of Australian schoolchildren. III. Effect of exposure to environmental allergens. Clin Allergy. 1987 Jul;17(4):291–300. doi: 10.1111/j.1365-2222.1987.tb02017.x. [DOI] [PubMed] [Google Scholar]
  443. Peck M. J., Piper P. J., Williams T. J. The effect of leukotrienes C4 and D4 on the microvasculature of guinea-pig skin. Prostaglandins. 1981 Feb;21(2):315–321. doi: 10.1016/0090-6980(81)90149-0. [DOI] [PubMed] [Google Scholar]
  444. Peden D. B., Boehlecke B., Horstman D., Devlin R. Prolonged acute exposure to 0.16 ppm ozone induces eosinophilic airway inflammation in asthmatic subjects with allergies. J Allergy Clin Immunol. 1997 Dec;100(6 Pt 1):802–808. doi: 10.1016/s0091-6749(97)70277-x. [DOI] [PubMed] [Google Scholar]
  445. Pedersen S., Frost L., Arnfred T. Errors in inhalation technique and efficiency in inhaler use in asthmatic children. Allergy. 1986 Feb;41(2):118–124. doi: 10.1111/j.1398-9995.1986.tb00287.x. [DOI] [PubMed] [Google Scholar]
  446. Pedersen S., Hansen O. R. Budesonide treatment of moderate and severe asthma in children: a dose-response study. J Allergy Clin Immunol. 1995 Jan;95(1 Pt 1):29–33. doi: 10.1016/s0091-6749(95)70149-4. [DOI] [PubMed] [Google Scholar]
  447. Pedersen S. Inhaler use in children with asthma. Dan Med Bull. 1987 Oct;34(5):234–249. [PubMed] [Google Scholar]
  448. Pedersen S., O'Byrne P. A comparison of the efficacy and safety of inhaled corticosteroids in asthma. Allergy. 1997;52(39 Suppl):1–34. doi: 10.1111/j.1398-9995.1997.tb05047.x. [DOI] [PubMed] [Google Scholar]
  449. Pekkanen J., Timonen K. L., Ruuskanen J., Reponen A., Mirme A. Effects of ultrafine and fine particles in urban air on peak expiratory flow among children with asthmatic symptoms. Environ Res. 1997;74(1):24–33. doi: 10.1006/enrs.1997.3750. [DOI] [PubMed] [Google Scholar]
  450. Perlow J. H., Montgomery D., Morgan M. A., Towers C. V., Porto M. Severity of asthma and perinatal outcome. Am J Obstet Gynecol. 1992 Oct;167(4 Pt 1):963–967. doi: 10.1016/s0002-9378(12)80020-2. [DOI] [PubMed] [Google Scholar]
  451. Peroni D. G., Boner A. L., Vallone G., Antolini I., Warner J. O. Effective allergen avoidance at high altitude reduces allergen-induced bronchial hyperresponsiveness. Am J Respir Crit Care Med. 1994 Jun;149(6):1442–1446. doi: 10.1164/ajrccm.149.6.8004296. [DOI] [PubMed] [Google Scholar]
  452. Peroni D. G., Piacentini G. L., Martinati L. C., Warner J. O., Boner A. L. Double-blind trial of house-dust mite immunotherapy in asthmatic children resident at high altitude. Allergy. 1995 Nov;50(11):925–930. doi: 10.1111/j.1398-9995.1995.tb02500.x. [DOI] [PubMed] [Google Scholar]
  453. Persson G., Olsson B., Soliman S. The impact of inspiratory effort on inspiratory flow through Turbuhaler in asthmatic patients. Eur Respir J. 1997 Mar;10(3):681–684. [PubMed] [Google Scholar]
  454. Peters A., Wichmann H. E., Tuch T., Heinrich J., Heyder J. Respiratory effects are associated with the number of ultrafine particles. Am J Respir Crit Care Med. 1997 Apr;155(4):1376–1383. doi: 10.1164/ajrccm.155.4.9105082. [DOI] [PubMed] [Google Scholar]
  455. Phipps P. R., Gonda I. Droplets produced by medical nebulizers. Some factors affecting their size and solute concentration. Chest. 1990 Jun;97(6):1327–1332. doi: 10.1378/chest.97.6.1327. [DOI] [PubMed] [Google Scholar]
  456. Platts-Mills T. A., Tovey E. R., Mitchell E. B., Moszoro H., Nock P., Wilkins S. R. Reduction of bronchial hyperreactivity during prolonged allergen avoidance. Lancet. 1982 Sep 25;2(8300):675–678. doi: 10.1016/s0140-6736(82)90709-7. [DOI] [PubMed] [Google Scholar]
  457. Platts-Mills T. A., Vervloet D., Thomas W. R., Aalberse R. C., Chapman M. D. Indoor allergens and asthma: report of the Third International Workshop. J Allergy Clin Immunol. 1997 Dec;100(6 Pt 1):S2–24. doi: 10.1016/s0091-6749(97)70292-6. [DOI] [PubMed] [Google Scholar]
  458. Plotnick L. H., Ducharme F. M. Should inhaled anticholinergics be added to beta2 agonists for treating acute childhood and adolescent asthma? A systematic review. BMJ. 1998 Oct 10;317(7164):971–977. doi: 10.1136/bmj.317.7164.971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  459. Pollard S. J., Spector S. L., Yancey S. W., Cox F. M., Emmett A. Salmeterol versus theophylline in the treatment of asthma. Ann Allergy Asthma Immunol. 1997 May;78(5):457–464. doi: 10.1016/S1081-1206(10)63232-2. [DOI] [PubMed] [Google Scholar]
  460. Pope C. A., 3rd, Dockery D. W. Acute health effects of PM10 pollution on symptomatic and asymptomatic children. Am Rev Respir Dis. 1992 May;145(5):1123–1128. doi: 10.1164/ajrccm/145.5.1123. [DOI] [PubMed] [Google Scholar]
  461. Price J. F., Russell G., Hindmarsh P. C., Weller P., Heaf D. P., Williams J. Growth during one year of treatment with fluticasone propionate or sodium cromoglycate in children with asthma. Pediatr Pulmonol. 1997 Sep;24(3):178–186. doi: 10.1002/(sici)1099-0496(199709)24:3<178::aid-ppul3>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  462. Provencher S., Labrèche F. P., De Guire L. Physician based surveillance system for occupational respiratory diseases: the experience of PROPULSE, Québec, Canada. Occup Environ Med. 1997 Apr;54(4):272–276. doi: 10.1136/oem.54.4.272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  463. Quirce S., Contreras G., Dybuncio A., Chan-Yeung M. Peak expiratory flow monitoring is not a reliable method for establishing the diagnosis of occupational asthma. Am J Respir Crit Care Med. 1995 Sep;152(3):1100–1102. doi: 10.1164/ajrccm.152.3.7663790. [DOI] [PubMed] [Google Scholar]
  464. Qureshi F., Pestian J., Davis P., Zaritsky A. Effect of nebulized ipratropium on the hospitalization rates of children with asthma. N Engl J Med. 1998 Oct 8;339(15):1030–1035. doi: 10.1056/NEJM199810083391503. [DOI] [PubMed] [Google Scholar]
  465. Rager K. J., Langland J. O., Jacobs B. L., Proud D., Marsh D. G., Imani F. Activation of antiviral protein kinase leads to immunoglobulin E class switching in human B cells. J Virol. 1998 Feb;72(2):1171–1176. doi: 10.1128/jvi.72.2.1171-1176.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  466. Raimondi A. C., Schottlender J., Lombardi D., Molfino N. A. Treatment of acute severe asthma with inhaled albuterol delivered via jet nebulizer, metered dose inhaler with spacer, or dry powder. Chest. 1997 Jul;112(1):24–28. doi: 10.1378/chest.112.1.24. [DOI] [PubMed] [Google Scholar]
  467. Ramage L., Lipworth B. J., Ingram C. G., Cree I. A., Dhillon D. P. Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol. Respir Med. 1994 May;88(5):363–368. doi: 10.1016/0954-6111(94)90042-6. [DOI] [PubMed] [Google Scholar]
  468. Ramage L., Lipworth B. J., Ingram C. G., Cree I. A., Dhillon D. P. Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol. Respir Med. 1994 May;88(5):363–368. doi: 10.1016/0954-6111(94)90042-6. [DOI] [PubMed] [Google Scholar]
  469. Rea H. H., Scragg R., Jackson R., Beaglehole R., Fenwick J., Sutherland D. C. A case-control study of deaths from asthma. Thorax. 1986 Nov;41(11):833–839. doi: 10.1136/thx.41.11.833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  470. Rea H. H., Sears M. R., Beaglehole R., Fenwick J., Jackson R. T., Gillies A. J., O'Donnell T. V., Holst P. E., Rothwell R. P. Lessons from the national asthma mortality study: circumstances surrounding death. N Z Med J. 1987 Jan 28;100(816):10–13. [PubMed] [Google Scholar]
  471. Rebuck A. S., Chapman K. R., Abboud R., Pare P. D., Kreisman H., Wolkove N., Vickerson F. Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room. Am J Med. 1987 Jan;82(1):59–64. doi: 10.1016/0002-9343(87)90378-0. [DOI] [PubMed] [Google Scholar]
  472. Rebuck A. S., Gent M., Chapman K. R. Anticholinergic and sympathomimetic combination therapy of asthma. J Allergy Clin Immunol. 1983 Mar;71(3):317–323. doi: 10.1016/0091-6749(83)90086-6. [DOI] [PubMed] [Google Scholar]
  473. Rebuck A. S., Kesten S., Boulet L. P., Cartier A., Cockcroft D., Gruber J., Laberge F., Lee-Chuy E., Keshmiri M., MacDonald G. F. A 3-month evaluation of the efficacy of nedocromil sodium in asthma: a randomized, double-blind, placebo-controlled trial of nedocromil sodium conducted by a Canadian multicenter study group. J Allergy Clin Immunol. 1990 Mar;85(3):612–617. doi: 10.1016/0091-6749(90)90101-9. [DOI] [PubMed] [Google Scholar]
  474. Reed C. E., Offord K. P., Nelson H. S., Li J. T., Tinkelman D. G. Aerosol beclomethasone dipropionate spray compared with theophylline as primary treatment for chronic mild-to-moderate asthma. The American Academy of Allergy, Asthma and Immunology Beclomethasone Dipropionate-Theophylline Study Group. J Allergy Clin Immunol. 1998 Jan;101(1 Pt 1):14–23. doi: 10.1016/s0091-6749(98)70187-3. [DOI] [PubMed] [Google Scholar]
  475. Reilly D., Taylor M. A., Beattie N. G., Campbell J. H., McSharry C., Aitchison T. C., Carter R., Stevenson R. D. Is evidence for homoeopathy reproducible? Lancet. 1994 Dec 10;344(8937):1601–1606. doi: 10.1016/s0140-6736(94)90407-3. [DOI] [PubMed] [Google Scholar]
  476. Reisman R. E., Mauriello P. M., Davis G. B., Georgitis J. W., DeMasi J. M. A double-blind study of the effectiveness of a high-efficiency particulate air (HEPA) filter in the treatment of patients with perennial allergic rhinitis and asthma. J Allergy Clin Immunol. 1990 Jun;85(6):1050–1057. doi: 10.1016/0091-6749(90)90050-e. [DOI] [PubMed] [Google Scholar]
  477. Reiss T. F., Altman L. C., Chervinsky P., Bewtra A., Stricker W. E., Noonan G. P., Kundu S., Zhang J. Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma. J Allergy Clin Immunol. 1996 Sep;98(3):528–534. doi: 10.1016/s0091-6749(96)70086-6. [DOI] [PubMed] [Google Scholar]
  478. Reiss T. F., Chervinsky P., Dockhorn R. J., Shingo S., Seidenberg B., Edwards T. B. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group. Arch Intern Med. 1998 Jun 8;158(11):1213–1220. doi: 10.1001/archinte.158.11.1213. [DOI] [PubMed] [Google Scholar]
  479. Rivington R. N., Boulet L. P., Côté J., Kreisman H., Small D. I., Alexander M., Day A., Harsanyi Z., Darke A. C. Efficacy of Uniphyl, salbutamol, and their combination in asthmatic patients on high-dose inhaled steroids. Am J Respir Crit Care Med. 1995 Feb;151(2 Pt 1):325–332. doi: 10.1164/ajrccm.151.2.7842186. [DOI] [PubMed] [Google Scholar]
  480. Rivington R. N., Calcutt L., Child S., MacLeod J. P., Hodder R. V., Stewart J. H. Comparison of morning versus evening dosing with a new once-daily oral theophylline formulation. Am J Med. 1985 Dec 20;79(6A):67–72. doi: 10.1016/0002-9343(85)90092-0. [DOI] [PubMed] [Google Scholar]
  481. Rivington R. N., Calcutt L., Hodder R. V., Stewart J. H., Aitken T. L. Safety and efficacy of once-daily Uniphyl tablets compared with twice-daily Theo-Dur tablets in elderly patients with chronic airflow obstruction. Am J Med. 1988 Jul 29;85(1B):48–53. doi: 10.1016/0002-9343(88)90242-2. [DOI] [PubMed] [Google Scholar]
  482. Roberts J. A., Gunneberg A., Elliott J. A., Thomson N. C. Hydroxychloroquine in steroid dependent asthma. Pulm Pharmacol. 1988;1(1):59–61. doi: 10.1016/0952-0600(88)90012-9. [DOI] [PubMed] [Google Scholar]
  483. Robertson C. E., Steedman D., Sinclair C. J., Brown D., Malcolm-Smith N. Use of ether in life-threatening acute severe asthma. Lancet. 1985 Jan 26;1(8422):187–188. doi: 10.1016/s0140-6736(85)92025-2. [DOI] [PubMed] [Google Scholar]
  484. Robertson C. F., Smith F., Beck R., Levison H. Response to frequent low doses of nebulized salbutamol in acute asthma. J Pediatr. 1985 Apr;106(4):672–674. doi: 10.1016/s0022-3476(85)80101-3. [DOI] [PubMed] [Google Scholar]
  485. Robinson P. J., Hegele R. G., Schellenberg R. R. Allergic sensitization increases airway reactivity in guinea pigs with respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol. 1997 Oct;100(4):492–498. doi: 10.1016/s0091-6749(97)70141-6. [DOI] [PubMed] [Google Scholar]
  486. Ronchetti R., Indinnimeo L., Bonci E., Corrias A., Evans D., Hindi-Alexander M., Midulla F., Pulejo R., Villa M. P. Asthma self-management programmes in a population of Italian children: a multicentric study. Italian Study Group on Asthma Self-Management Programmes. Eur Respir J. 1997 Jun;10(6):1248–1253. doi: 10.1183/09031936.97.10061248. [DOI] [PubMed] [Google Scholar]
  487. Rosenstreich D. L., Eggleston P., Kattan M., Baker D., Slavin R. G., Gergen P., Mitchell H., McNiff-Mortimer K., Lynn H., Ownby D. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma. N Engl J Med. 1997 May 8;336(19):1356–1363. doi: 10.1056/NEJM199705083361904. [DOI] [PubMed] [Google Scholar]
  488. Ross R. N., Morris M., Sakowitz S. R., Berman B. A. Cost-effectiveness of including cromolyn sodium in the treatment program for asthma: a retrospective, record-based study. Clin Ther. 1988;10(2):188–203. [PubMed] [Google Scholar]
  489. Rossing T. H., Fanta C. H., Goldstein D. H., Snapper J. R., McFadden E. R., Jr Emergency therapy of asthma: comparison of the acute effects of parenteral and inhaled sympathomimetics and infused aminophylline. Am Rev Respir Dis. 1980 Sep;122(3):365–371. doi: 10.1164/arrd.1980.122.3.365. [DOI] [PubMed] [Google Scholar]
  490. Rossing T. H., Fanta C. H., McFadden E. R., Jr Effect of outpatient treatment of asthma with beta agonists on the response to sympathomimetics in an emergency room. Am J Med. 1983 Nov;75(5):781–784. doi: 10.1016/0002-9343(83)90407-2. [DOI] [PubMed] [Google Scholar]
  491. Roux F. J., Grandordy B., Douglas J. S. Functional and binding characteristics of long-acting beta 2-agonists in lung and heart. Am J Respir Crit Care Med. 1996 May;153(5):1489–1495. doi: 10.1164/ajrccm.153.5.8630591. [DOI] [PubMed] [Google Scholar]
  492. Rowe B. H., Keller J. L., Oxman A. D. Effectiveness of steroid therapy in acute exacerbations of asthma: a meta-analysis. Am J Emerg Med. 1992 Jul;10(4):301–310. doi: 10.1016/0735-6757(92)90007-k. [DOI] [PubMed] [Google Scholar]
  493. Rubin D. H., Leventhal J. M., Sadock R. T., Letovsky E., Schottland P., Clemente I., McCarthy P. Educational intervention by computer in childhood asthma: a randomized clinical trial testing the use of a new teaching intervention in childhood asthma. Pediatrics. 1986 Jan;77(1):1–10. [PubMed] [Google Scholar]
  494. Rusznak C., Devalia J. L., Davies R. J. Airway response of asthmatic subjects to inhaled allergen after exposure to pollutants. Thorax. 1996 Nov;51(11):1105–1108. doi: 10.1136/thx.51.11.1105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  495. Ryan G., Latimer K. M., Dolovich J., Hargreave F. E. Bronchial responsiveness to histamine: relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway calibre. Thorax. 1982 Jun;37(6):423–429. doi: 10.1136/thx.37.6.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  496. Rønborg S. M., Mosbech H., Poulsen L. K. Exposure chamber for allergen challenge. A placebo-controlled, double-blind trial in house-dust-mite asthma. Allergy. 1997 Aug;52(8):821–828. doi: 10.1111/j.1398-9995.1997.tb02153.x. [DOI] [PubMed] [Google Scholar]
  497. Sackner M. A., Ford D., Fernandez R., Cipley J., Perez D., Kwoka M., Reinhart M., Michaelson E. D., Schreck R., Wanner A. Effects of sulfuric acid aerosol on cardiopulmonary function of dogs, sheep, and humans. Am Rev Respir Dis. 1978 Sep;118(3):497–510. doi: 10.1164/arrd.1978.118.3.497. [DOI] [PubMed] [Google Scholar]
  498. Sagai M., Furuyama A., Ichinose T. Biological effects of diesel exhaust particles (DEP). III. Pathogenesis of asthma like symptoms in mice. Free Radic Biol Med. 1996;21(2):199–209. doi: 10.1016/0891-5849(96)00032-9. [DOI] [PubMed] [Google Scholar]
  499. Salmeron S., Brochard L., Mal H., Tenaillon A., Henry-Amar M., Renon D., Duroux P., Simonneau G. Nebulized versus intravenous albuterol in hypercapnic acute asthma. A multicenter, double-blind, randomized study. Am J Respir Crit Care Med. 1994 Jun;149(6):1466–1470. doi: 10.1164/ajrccm.149.6.8004299. [DOI] [PubMed] [Google Scholar]
  500. Sampson A. P., Castling D. P., Green C. P., Price J. F. Persistent increase in plasma and urinary leukotrienes after acute asthma. Arch Dis Child. 1995 Sep;73(3):221–225. doi: 10.1136/adc.73.3.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  501. Saneyoshi K., Nohara O., Imai T., Shiraishi F., Moriyama H., Fujimaki H. IL-4 and IL-6 production of bone marrow-derived mast cells is enhanced by treatment with environmental pollutants. Int Arch Allergy Immunol. 1997 Nov;114(3):237–245. doi: 10.1159/000237674. [DOI] [PubMed] [Google Scholar]
  502. Sarpong S. B., Karrison T. Sensitization to indoor allergens and the risk for asthma hospitalization in children. Ann Allergy Asthma Immunol. 1997 Nov;79(5):455–459. doi: 10.1016/S1081-1206(10)63043-8. [DOI] [PubMed] [Google Scholar]
  503. Sarpong S. B., Wood R. A., Eggleston P. A. Short-term effects of extermination and cleaning on cockroach allergen Bla g 2 in settled dust. Ann Allergy Asthma Immunol. 1996 Mar;76(3):257–260. doi: 10.1016/S1081-1206(10)63437-0. [DOI] [PubMed] [Google Scholar]
  504. Saulnier F. F., Durocher A. V., Deturck R. A., Lefèbvre M. C., Wattel F. E. Respiratory and hemodynamic effects of halothane in status asthmaticus. Intensive Care Med. 1990;16(2):104–107. doi: 10.1007/BF02575303. [DOI] [PubMed] [Google Scholar]
  505. Scannell C., Chen L., Aris R. M., Tager I., Christian D., Ferrando R., Welch B., Kelly T., Balmes J. R. Greater ozone-induced inflammatory responses in subjects with asthma. Am J Respir Crit Care Med. 1996 Jul;154(1):24–29. doi: 10.1164/ajrccm.154.1.8680687. [DOI] [PubMed] [Google Scholar]
  506. Schatz M., Harden K., Forsythe A., Chilingar L., Hoffman C., Sperling W., Zeiger R. S. The course of asthma during pregnancy, post partum, and with successive pregnancies: a prospective analysis. J Allergy Clin Immunol. 1988 Mar;81(3):509–517. [PubMed] [Google Scholar]
  507. Schatz M., Zeiger R. S., Harden K. M., Hoffman C. P., Forsythe A. B., Chilingar L. M., Porreco R. P., Benenson A. S., Sperling W. L., Saunders B. S. The safety of inhaled beta-agonist bronchodilators during pregnancy. J Allergy Clin Immunol. 1988 Oct;82(4):686–695. doi: 10.1016/0091-6749(88)90984-0. [DOI] [PubMed] [Google Scholar]
  508. Schatz M., Zeiger R. S., Harden K., Hoffman C. C., Chilingar L., Petitti D. The safety of asthma and allergy medications during pregnancy. J Allergy Clin Immunol. 1997 Sep;100(3):301–306. doi: 10.1016/s0091-6749(97)70241-0. [DOI] [PubMed] [Google Scholar]
  509. Schatz M., Zeiger R. S., Hoffman C. P., Harden K., Forsythe A., Chilingar L., Saunders B., Porreco R., Sperling W., Kagnoff M. Perinatal outcomes in the pregnancies of asthmatic women: a prospective controlled analysis. Am J Respir Crit Care Med. 1995 Apr;151(4):1170–1174. doi: 10.1164/ajrccm/151.4.1170. [DOI] [PubMed] [Google Scholar]
  510. Schlaeppi M., Edwards K., Fuller R. W., Sharma R. Patient perception of the diskus inhaler: a comparison with the turbuhaler inhaler. Br J Clin Pract. 1996 Jan-Feb;50(1):14–19. [PubMed] [Google Scholar]
  511. Schlieper A., Alcock D., Beaudry P., Feldman W., Leikin L. Effect of therapeutic plasma concentrations of theophylline on behavior, cognitive processing, and affect in children with asthma. J Pediatr. 1991 Mar;118(3):449–455. doi: 10.1016/s0022-3476(05)82167-5. [DOI] [PubMed] [Google Scholar]
  512. Schwartz H. J., Lowell F. C., Melby J. C. Steroid resistance in bronchial asthma. Ann Intern Med. 1968 Sep;69(3):493–499. doi: 10.7326/0003-4819-69-3-493. [DOI] [PubMed] [Google Scholar]
  513. Schwartz J., Slater D., Larson T. V., Pierson W. E., Koenig J. Q. Particulate air pollution and hospital emergency room visits for asthma in Seattle. Am Rev Respir Dis. 1993 Apr;147(4):826–831. doi: 10.1164/ajrccm/147.4.826. [DOI] [PubMed] [Google Scholar]
  514. Schwartz S. H. Treatment of status asthmaticus with halothane. JAMA. 1984 May 25;251(20):2688–2689. [PubMed] [Google Scholar]
  515. Schwarze J., Hamelmann E., Bradley K. L., Takeda K., Gelfand E. W. Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen. J Clin Invest. 1997 Jul 1;100(1):226–233. doi: 10.1172/JCI119516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  516. Sears M. R., Taylor D. R., Print C. G., Lake D. C., Li Q. Q., Flannery E. M., Yates D. M., Lucas M. K., Herbison G. P. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet. 1990 Dec 8;336(8728):1391–1396. doi: 10.1016/0140-6736(90)93098-a. [DOI] [PubMed] [Google Scholar]
  517. Sears M. R., Taylor D. R. The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology. Drug Saf. 1994 Oct;11(4):259–283. doi: 10.2165/00002018-199411040-00005. [DOI] [PubMed] [Google Scholar]
  518. Selroos O., Pietinalho A., Löfroos A. B., Riska H. Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest. 1995 Nov;108(5):1228–1234. doi: 10.1378/chest.108.5.1228. [DOI] [PubMed] [Google Scholar]
  519. Shapiro G. G., Sharpe M., DeRouen T. A., Pierson W. E., Furukawa C. T., Virant F. S., Bierman C. W. Cromolyn versus triamcinolone acetonide for youngsters with moderate asthma. J Allergy Clin Immunol. 1991 Nov;88(5):742–748. doi: 10.1016/0091-6749(91)90181-m. [DOI] [PubMed] [Google Scholar]
  520. Shapiro G., Mendelson L., Kraemer M. J., Cruz-Rivera M., Walton-Bowen K., Smith J. A. Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid-dependent, persistent asthma. J Allergy Clin Immunol. 1998 Nov;102(5):789–796. doi: 10.1016/s0091-6749(98)70019-3. [DOI] [PubMed] [Google Scholar]
  521. Shim C. S., Williams M. H., Jr Effect of bronchodilator therapy administered by canister versus jet nebulizer. J Allergy Clin Immunol. 1984 Mar;73(3):387–390. doi: 10.1016/0091-6749(84)90413-5. [DOI] [PubMed] [Google Scholar]
  522. Shim C. S., Williams M. H., Jr Evaluation of the severity of asthma: patients versus physicians. Am J Med. 1980 Jan;68(1):11–13. doi: 10.1016/0002-9343(80)90155-2. [DOI] [PubMed] [Google Scholar]
  523. Shim C. S., Williams M. H., Jr Relationship of wheezing to the severity of obstruction in asthma. Arch Intern Med. 1983 May;143(5):890–892. [PubMed] [Google Scholar]
  524. Shim C. S., Williams M. H., Jr Relationship of wheezing to the severity of obstruction in asthma. Arch Intern Med. 1983 May;143(5):890–892. [PubMed] [Google Scholar]
  525. Shulimzon T. R., Shiner R. J. A risk-benefit assessment of methotrexate in corticosteroid-dependent asthma. Drug Saf. 1996 Oct;15(4):283–290. doi: 10.2165/00002018-199615040-00006. [DOI] [PubMed] [Google Scholar]
  526. Sigman K., Mazer B. Immunotherapy for childhood asthma: is there a rationale for its use? Ann Allergy Asthma Immunol. 1996 Apr;76(4):299–309. doi: 10.1016/S1081-1206(10)60029-4. [DOI] [PubMed] [Google Scholar]
  527. Sigurs N., Hattevig G., Kjellman B., Kjellman N. I., Nilsson L., Björkstén B. Appearance of atopic disease in relation to serum IgE antibodies in children followed up from birth for 4 to 15 years. J Allergy Clin Immunol. 1994 Oct;94(4):757–763. doi: 10.1016/0091-6749(94)90184-8. [DOI] [PubMed] [Google Scholar]
  528. Sihra B. S., Kon O. M., Durham S. R., Walker S., Barnes N. C., Kay A. B. Effect of cyclosporin A on the allergen-induced late asthmatic reaction. Thorax. 1997 May;52(5):447–452. doi: 10.1136/thx.52.5.447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  529. Silverstein M. D., Yunginger J. W., Reed C. E., Petterson T., Zimmerman D., Li J. T., O'Fallon W. M. Attained adult height after childhood asthma: effect of glucocorticoid therapy. J Allergy Clin Immunol. 1997 Apr;99(4):466–474. doi: 10.1016/s0091-6749(97)70072-1. [DOI] [PubMed] [Google Scholar]
  530. Simons F. E. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. N Engl J Med. 1997 Dec 4;337(23):1659–1665. doi: 10.1056/NEJM199712043372304. [DOI] [PubMed] [Google Scholar]
  531. Simons F. E. Benefits and risks of inhaled glucocorticoids in children with persistent asthma. J Allergy Clin Immunol. 1998 Nov;102(5):S77–S84. doi: 10.1016/s0091-6749(98)70035-1. [DOI] [PubMed] [Google Scholar]
  532. Simons F. E., Gerstner T. V., Cheang M. S. Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment. Pediatrics. 1997 May;99(5):655–659. doi: 10.1542/peds.99.5.655. [DOI] [PubMed] [Google Scholar]
  533. Simons F. E., Persaud M. P., Gillespie C. A., Cheang M., Shuckett E. P. Absence of posterior subcapsular cataracts in young patients treated with inhaled glucocorticoids. Lancet. 1993 Sep 25;342(8874):776–778. doi: 10.1016/0140-6736(93)91541-s. [DOI] [PubMed] [Google Scholar]
  534. Skloot G., Permutt S., Togias A. Airway hyperresponsiveness in asthma: a problem of limited smooth muscle relaxation with inspiration. J Clin Invest. 1995 Nov;96(5):2393–2403. doi: 10.1172/JCI118296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  535. Skobeloff E. M., Spivey W. H., McNamara R. M., Greenspon L. Intravenous magnesium sulfate for the treatment of acute asthma in the emergency department. JAMA. 1989 Sep 1;262(9):1210–1213. [PubMed] [Google Scholar]
  536. Skorodin M. S., Tenholder M. F., Yetter B., Owen K. A., Waller R. F., Khandelwahl S., Maki K., Rohail T., D'Alfonso N. Magnesium sulfate in exacerbations of chronic obstructive pulmonary disease. Arch Intern Med. 1995 Mar 13;155(5):496–500. [PubMed] [Google Scholar]
  537. Sly P. D., Cahill P., Willet K., Burton P. Accuracy of mini peak flow meters in indicating changes in lung function in children with asthma. BMJ. 1994 Feb 26;308(6928):572–574. doi: 10.1136/bmj.308.6928.572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  538. Sly P. D., Landau L. I., Weymouth R. Home recording of peak expiratory flow rates and perception of asthma. Am J Dis Child. 1985 May;139(5):479–482. doi: 10.1001/archpedi.1985.02140070053032. [DOI] [PubMed] [Google Scholar]
  539. Solway J., Fredberg J. J. Perhaps airway smooth muscle dysfunction contributes to asthmatic bronchial hyperresponsiveness after all. Am J Respir Cell Mol Biol. 1997 Aug;17(2):144–146. doi: 10.1165/ajrcmb.17.2.f137. [DOI] [PubMed] [Google Scholar]
  540. Spahn J. D., Leung D. Y., Szefler S. J. New insights into the pathogenesis and management of steroid-resistant asthma. J Asthma. 1997;34(3):177–194. doi: 10.3109/02770909709068188. [DOI] [PubMed] [Google Scholar]
  541. Spector S. L., Smith L. J., Glass M. Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group. Am J Respir Crit Care Med. 1994 Sep;150(3):618–623. doi: 10.1164/ajrccm.150.3.8087328. [DOI] [PubMed] [Google Scholar]
  542. Spigelblatt L., Laîné-Ammara G., Pless I. B., Guyver A. The use of alternative medicine by children. Pediatrics. 1994 Dec;94(6 Pt 1):811–814. [PubMed] [Google Scholar]
  543. Spitzer W. O., Suissa S., Ernst P., Horwitz R. I., Habbick B., Cockcroft D., Boivin J. F., McNutt M., Buist A. S., Rebuck A. S. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med. 1992 Feb 20;326(8):501–506. doi: 10.1056/NEJM199202203260801. [DOI] [PubMed] [Google Scholar]
  544. Spitzer W. O., Suissa S., Ernst P., Horwitz R. I., Habbick B., Cockcroft D., Boivin J. F., McNutt M., Buist A. S., Rebuck A. S. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med. 1992 Feb 20;326(8):501–506. doi: 10.1056/NEJM199202203260801. [DOI] [PubMed] [Google Scholar]
  545. Sporik R., Holgate S. T., Platts-Mills T. A., Cogswell J. J. Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study. N Engl J Med. 1990 Aug 23;323(8):502–507. doi: 10.1056/NEJM199008233230802. [DOI] [PubMed] [Google Scholar]
  546. Squillace S. P., Sporik R. B., Rakes G., Couture N., Lawrence A., Merriam S., Zhang J., Platts-Mills A. E. Sensitization to dust mites as a dominant risk factor for asthma among adolescents living in central Virginia. Multiple regression analysis of a population-based study. Am J Respir Crit Care Med. 1997 Dec;156(6):1760–1764. doi: 10.1164/ajrccm.156.6.9704026. [DOI] [PubMed] [Google Scholar]
  547. Steerenberg P. A., Zonnenberg J. A., Dormans J. A., Joon P. N., Wouters I. M., van Bree L., Scheepers P. T., Van Loveren H. Diesel exhaust particles induced release of interleukin 6 and 8 by (primed) human bronchial epithelial cells (BEAS 2B) in vitro. Exp Lung Res. 1998 Jan-Feb;24(1):85–100. doi: 10.3109/01902149809046056. [DOI] [PubMed] [Google Scholar]
  548. Strand V., Rak S., Svartengren M., Bylin G. Nitrogen dioxide exposure enhances asthmatic reaction to inhaled allergen in subjects with asthma. Am J Respir Crit Care Med. 1997 Mar;155(3):881–887. doi: 10.1164/ajrccm.155.3.9117021. [DOI] [PubMed] [Google Scholar]
  549. Stross J. K., Bole G. G. Evaluation of a continuing education program in rheumatoid arthritis. Arthritis Rheum. 1980 Jul;23(7):846–849. doi: 10.1002/art.1780230711. [DOI] [PubMed] [Google Scholar]
  550. Suissa S., Dennis R., Ernst P., Sheehy O., Wood-Dauphinee S. Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1997 Feb 1;126(3):177–183. doi: 10.7326/0003-4819-126-3-199702010-00001. [DOI] [PubMed] [Google Scholar]
  551. Suissa S., Ernst P., Boivin J. F., Horwitz R. I., Habbick B., Cockroft D., Blais L., McNutt M., Buist A. S., Spitzer W. O. A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med. 1994 Mar;149(3 Pt 1):604–610. doi: 10.1164/ajrccm.149.3.8118625. [DOI] [PubMed] [Google Scholar]
  552. Sullivan P., Bekir S., Jaffar Z., Page C., Jeffery P., Costello J. Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. Lancet. 1994 Apr 23;343(8904):1006–1008. doi: 10.1016/s0140-6736(94)90127-9. [DOI] [PubMed] [Google Scholar]
  553. Summer W., Elston R., Tharpe L., Nelson S., Haponik E. F. Aerosol bronchodilator delivery methods. Relative impact on pulmonary function and cost of respiratory care. Arch Intern Med. 1989 Mar;149(3):618–623. doi: 10.1001/archinte.149.3.618. [DOI] [PubMed] [Google Scholar]
  554. Summers Q. A., Tarala R. A. Nebulized ipratropium in the treatment of acute asthma. Chest. 1990 Feb;97(2):425–429. doi: 10.1378/chest.97.2.425. [DOI] [PubMed] [Google Scholar]
  555. Suzuki T., Kanoh T., Ishimori M., Ikeda S., Ohkuni H. Adjuvant activity of diesel exhaust particulates (DEP) in production of anti-IgE and anti-IgG1 antibodies to mite allergen in mice. J Clin Lab Immunol. 1996;48(5):187–199. [PubMed] [Google Scholar]
  556. Svartengren K., Lindestad P., Svartengren M., Philipson K., Bylin G., Camner P. Added external resistance reduces oropharyngeal deposition and increases lung deposition of aerosol particles in asthmatics. Am J Respir Crit Care Med. 1995 Jul;152(1):32–37. doi: 10.1164/ajrccm.152.1.7599841. [DOI] [PubMed] [Google Scholar]
  557. Svendsen U. G., Frølund L., Madsen F., Nielsen N. H. A comparison of the effects of nedocromil sodium and beclomethasone dipropionate on pulmonary function, symptoms, and bronchial responsiveness in patients with asthma. J Allergy Clin Immunol. 1989 Aug;84(2):224–231. doi: 10.1016/0091-6749(89)90329-1. [DOI] [PubMed] [Google Scholar]
  558. Svendsen U. G., Frølund L., Madsen F., Nielsen N. H., Holstein-Rathlou N. H., Weeke B. A comparison of the effects of sodium cromoglycate and beclomethasone dipropionate on pulmonary function and bronchial hyperreactivity in subjects with asthma. J Allergy Clin Immunol. 1987 Jul;80(1):68–74. doi: 10.1016/s0091-6749(87)80193-8. [DOI] [PubMed] [Google Scholar]
  559. Szczeklik A., Nizankowska E., Dworski R., Domagala B., Pinis G. Cyclosporin for steroid-dependent asthma. Allergy. 1991 May;46(4):312–315. doi: 10.1111/j.1398-9995.1991.tb00590.x. [DOI] [PubMed] [Google Scholar]
  560. Taggart V. S., Zuckerman A. E., Sly R. M., Steinmueller C., Newman G., O'Brien R. W., Schneider S., Bellanti J. A. You Can Control Asthma: evaluation of an asthma education program for hospitalized inner-city children. Patient Educ Couns. 1991 Feb;17(1):35–47. doi: 10.1016/0738-3991(91)90049-b. [DOI] [PubMed] [Google Scholar]
  561. Takafuji S., Suzuki S., Koizumi K., Tadokoro K., Miyamoto T., Ikemori R., Muranaka M. Diesel-exhaust particulates inoculated by the intranasal route have an adjuvant activity for IgE production in mice. J Allergy Clin Immunol. 1987 Apr;79(4):639–645. doi: 10.1016/s0091-6749(87)80161-6. [DOI] [PubMed] [Google Scholar]
  562. Takano H., Yoshikawa T., Ichinose T., Miyabara Y., Imaoka K., Sagai M. Diesel exhaust particles enhance antigen-induced airway inflammation and local cytokine expression in mice. Am J Respir Crit Care Med. 1997 Jul;156(1):36–42. doi: 10.1164/ajrccm.156.1.9610054. [DOI] [PubMed] [Google Scholar]
  563. Takenaka H., Zhang K., Diaz-Sanchez D., Tsien A., Saxon A. Enhanced human IgE production results from exposure to the aromatic hydrocarbons from diesel exhaust: direct effects on B-cell IgE production. J Allergy Clin Immunol. 1995 Jan;95(1 Pt 1):103–115. doi: 10.1016/s0091-6749(95)70158-3. [DOI] [PubMed] [Google Scholar]
  564. Tal A., Golan H., Grauer N., Aviram M., Albin D., Quastel M. R. Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstruction. J Pediatr. 1996 Apr;128(4):479–484. doi: 10.1016/s0022-3476(96)70357-8. [DOI] [PubMed] [Google Scholar]
  565. Tamaoki J., Kondo M., Sakai N., Nakata J., Takemura H., Nagai A., Takizawa T., Konno K. Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group. Am J Respir Crit Care Med. 1997 Apr;155(4):1235–1240. doi: 10.1164/ajrccm.155.4.9105060. [DOI] [PubMed] [Google Scholar]
  566. Tandon M. K., Soh P. F., Wood A. T. Acupuncture for bronchial asthma? A double-blind crossover study. Med J Aust. 1991 Mar 18;154(6):409–412. [PubMed] [Google Scholar]
  567. Tanenbaum S. J. What physicians know. N Engl J Med. 1993 Oct 21;329(17):1268–1271. doi: 10.1056/NEJM199310213291713. [DOI] [PubMed] [Google Scholar]
  568. Tansey I. The technical transition to CFC-free inhalers. Br J Clin Pract Suppl. 1997 May;89:22–27. [PubMed] [Google Scholar]
  569. Tarlo S. M., Boulet L. P., Cartier A., Cockcroft D., Côtè J., Hargreave F. E., Holness L., Liss G., Malo J. L., Chan-Yeung M. Canadian Thoracic Society guidelines for occupational asthma. Can Respir J. 1998 Jul-Aug;5(4):289–300. doi: 10.1155/1998/587580. [DOI] [PubMed] [Google Scholar]
  570. Tarlo S. M., Broder I. Irritant-induced occupational asthma. Chest. 1989 Aug;96(2):297–300. doi: 10.1378/chest.96.2.297. [DOI] [PubMed] [Google Scholar]
  571. Tashkin D. P., Kroening R. J., Bresler D. E., Simmons M., Coulson A. H., Kerschnar H. A controlled trial of real and simulated acupuncture in the management of chronic asthma. J Allergy Clin Immunol. 1985 Dec;76(6):855–864. doi: 10.1016/0091-6749(85)90760-2. [DOI] [PubMed] [Google Scholar]
  572. Taylor D. R., Sears M. R. Bronchodilators and bronchial hyperresponsiveness. Thorax. 1994 Feb;49(2):190–191. doi: 10.1136/thx.49.2.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  573. Taylor D. R., Sears M. R., Herbison G. P., Flannery E. M., Print C. G., Lake D. C., Yates D. M., Lucas M. K., Li Q. Regular inhaled beta agonist in asthma: effects on exacerbations and lung function. Thorax. 1993 Feb;48(2):134–138. doi: 10.1136/thx.48.2.134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  574. Taylor D. R., Sears M. R., Herbison G. P., Flannery E. M., Print C. G., Lake D. C., Yates D. M., Lucas M. K., Li Q. Regular inhaled beta agonist in asthma: effects on exacerbations and lung function. Thorax. 1993 Feb;48(2):134–138. doi: 10.1136/thx.48.2.134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  575. Taylor G. W., Taylor I., Black P., Maltby N. H., Turner N., Fuller R. W., Dollery C. T. Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet. 1989 Mar 18;1(8638):584–588. doi: 10.1016/s0140-6736(89)91611-5. [DOI] [PubMed] [Google Scholar]
  576. Taylor I. K., O'Shaughnessy K. M., Fuller R. W., Dollery C. T. Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Lancet. 1991 Mar 23;337(8743):690–694. doi: 10.1016/0140-6736(91)90277-v. [DOI] [PubMed] [Google Scholar]
  577. Terajima M., Yamaya M., Sekizawa K., Okinaga S., Suzuki T., Yamada N., Nakayama K., Ohrui T., Oshima T., Numazaki Y. Rhinovirus infection of primary cultures of human tracheal epithelium: role of ICAM-1 and IL-1beta. Am J Physiol. 1997 Oct;273(4 Pt 1):L749–L759. doi: 10.1152/ajplung.1997.273.4.L749. [DOI] [PubMed] [Google Scholar]
  578. Terzano C., Mannino F. Probability of particle and salbutamol deposition in the respiratory tract: comparison between MDI and Autohaler. Monaldi Arch Chest Dis. 1996 Jun;51(3):236–242. [PubMed] [Google Scholar]
  579. Thapar A. Educating asthmatic patients in primary care: a pilot study of small group education. Fam Pract. 1994 Mar;11(1):39–43. doi: 10.1093/fampra/11.1.39. [DOI] [PubMed] [Google Scholar]
  580. Thomas S. H., O'Doherty M. J., Graham A., Page C. J., Blower P., Geddes D. M., Nunan T. O. Pulmonary deposition of nebulised amiloride in cystic fibrosis: comparison of two nebulisers. Thorax. 1991 Oct;46(10):717–721. doi: 10.1136/thx.46.10.717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  581. Thomas S. H., O'Doherty M. J., Page C. J., Nunan T. O., Bateman N. T. Which apparatus for inhaled pentamidine? A comparison of pulmonary deposition via eight nebulisers. Eur Respir J. 1991 May;4(5):616–622. [PubMed] [Google Scholar]
  582. Thorsson L., Dahlström K., Edsbäcker S., Källén A., Paulson J., Wirén J. E. Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects. Br J Clin Pharmacol. 1997 Feb;43(2):155–161. doi: 10.1046/j.1365-2125.1997.d01-1425.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  583. Thorsson L., Edsbäcker S., Conradson T. B. Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI. Eur Respir J. 1994 Oct;7(10):1839–1844. doi: 10.1183/09031936.94.07101839. [DOI] [PubMed] [Google Scholar]
  584. Thurston G. D., Ito K., Hayes C. G., Bates D. V., Lippmann M. Respiratory hospital admissions and summertime haze air pollution in Toronto, Ontario: consideration of the role of acid aerosols. Environ Res. 1994 May;65(2):271–290. doi: 10.1006/enrs.1994.1037. [DOI] [PubMed] [Google Scholar]
  585. Thurston G. D., Ito K., Kinney P. L., Lippmann M. A multi-year study of air pollution and respiratory hospital admissions in three New York State metropolitan areas: results for 1988 and 1989 summers. J Expo Anal Environ Epidemiol. 1992 Oct-Dec;2(4):429–450. [PubMed] [Google Scholar]
  586. Tiffany B. R., Berk W. A., Todd I. K., White S. R. Magnesium bolus or infusion fails to improve expiratory flow in acute asthma exacerbations. Chest. 1993 Sep;104(3):831–834. doi: 10.1378/chest.104.3.831. [DOI] [PubMed] [Google Scholar]
  587. Timonen K. L., Pekkanen J. Air pollution and respiratory health among children with asthmatic or cough symptoms. Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):546–552. doi: 10.1164/ajrccm.156.2.9608044. [DOI] [PubMed] [Google Scholar]
  588. Tinkelman D. G., Reed C. E., Nelson H. S., Offord K. P. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics. 1993 Jul;92(1):64–77. [PubMed] [Google Scholar]
  589. Toogood J. H., Baskerville J. C., Markov A. E., Hodsman A. B., Fraher L. J., Jennings B., Haddad R. G., Drost D. Bone mineral density and the risk of fracture in patients receiving long-term inhaled steroid therapy for asthma. J Allergy Clin Immunol. 1995 Aug;96(2):157–166. doi: 10.1016/s0091-6749(95)70003-x. [DOI] [PubMed] [Google Scholar]
  590. Toogood J. H. Complications of topical steroid therapy for asthma. Am Rev Respir Dis. 1990 Feb;141(2 Pt 2):S89–S96. [PubMed] [Google Scholar]
  591. Toogood J. H., Jennings B., Lefcoe N. M. A clinical trial of combined cromolyn/beclomethasone treatment for chronic asthma. J Allergy Clin Immunol. 1981 Apr;67(4):317–324. doi: 10.1016/0091-6749(81)90028-2. [DOI] [PubMed] [Google Scholar]
  592. Toogood J. H., Lefcoe N. M., Buck C., McCourtie D. R. A clinical index of disability due to chronic asthma tested during a trial of cromolyn sodium treatment. Chest. 1973 Jun;63(6):881–888. doi: 10.1378/chest.63.6.881. [DOI] [PubMed] [Google Scholar]
  593. Toogood J. H., Lefcoe N. M., Rose D. K., McCourtie D. R. A double-blind study of disodium cromoglycate for prophylaxis of bronchial asthma. Am Rev Respir Dis. 1971 Sep;104(3):323–330. doi: 10.1164/arrd.1971.104.3.323. [DOI] [PubMed] [Google Scholar]
  594. Toogood J. H., Markov A. E., Baskerville J., Dyson C. Association of ocular cataracts with inhaled and oral steroid therapy during long-term treatment of asthma. J Allergy Clin Immunol. 1993 Feb;91(2):571–579. doi: 10.1016/0091-6749(93)90263-f. [DOI] [PubMed] [Google Scholar]
  595. Toogood J. H. Side effects of inhaled corticosteroids. J Allergy Clin Immunol. 1998 Nov;102(5):705–713. doi: 10.1016/s0091-6749(98)70007-7. [DOI] [PubMed] [Google Scholar]
  596. Torphy T. J. Phosphodiesterase isozymes: molecular targets for novel antiasthma agents. Am J Respir Crit Care Med. 1998 Feb;157(2):351–370. doi: 10.1164/ajrccm.157.2.9708012. [DOI] [PubMed] [Google Scholar]
  597. Torén K. Self reported rate of occupational asthma in Sweden 1990-2. Occup Environ Med. 1996 Nov;53(11):757–761. doi: 10.1136/oem.53.11.757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  598. Tovey E. R., Chapman M. D., Wells C. W., Platts-Mills T. A. The distribution of dust mite allergen in the houses of patients with asthma. Am Rev Respir Dis. 1981 Nov;124(5):630–635. doi: 10.1164/arrd.1981.124.5.630. [DOI] [PubMed] [Google Scholar]
  599. Town I., Kwong T., Holst P., Beasley R. Use of a management plan for treating asthma in an emergency department. Thorax. 1990 Sep;45(9):702–706. doi: 10.1136/thx.45.9.702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  600. Troisi R. J., Speizer F. E., Willett W. C., Trichopoulos D., Rosner B. Menopause, postmenopausal estrogen preparations, and the risk of adult-onset asthma. A prospective cohort study. Am J Respir Crit Care Med. 1995 Oct;152(4 Pt 1):1183–1188. doi: 10.1164/ajrccm.152.4.7551368. [DOI] [PubMed] [Google Scholar]
  601. Tsien A., Diaz-Sanchez D., Ma J., Saxon A. The organic component of diesel exhaust particles and phenanthrene, a major polyaromatic hydrocarbon constituent, enhances IgE production by IgE-secreting EBV-transformed human B cells in vitro. Toxicol Appl Pharmacol. 1997 Feb;142(2):256–263. doi: 10.1006/taap.1996.8063. [DOI] [PubMed] [Google Scholar]
  602. Tunnicliffe W. S., Burge P. S., Ayres J. G. Effect of domestic concentrations of nitrogen dioxide on airway responses to inhaled allergen in asthmatic patients. Lancet. 1994 Dec 24;344(8939-8940):1733–1736. doi: 10.1016/s0140-6736(94)92886-x. [DOI] [PubMed] [Google Scholar]
  603. Turner K. J., Dowse G. K., Stewart G. A., Alpers M. P. Studies on bronchial hyperreactivity, allergic responsiveness, and asthma in rural and urban children of the highlands of Papua New Guinea. J Allergy Clin Immunol. 1986 Apr;77(4):558–566. doi: 10.1016/0091-6749(86)90345-3. [DOI] [PubMed] [Google Scholar]
  604. Turner M. O., Gafni A., Swan D., FitzGerald J. M. A review and economic evaluation of bronchodilator delivery methods in hospitalized patients. Arch Intern Med. 1996 Oct 14;156(18):2113–2118. [PubMed] [Google Scholar]
  605. Turner M. O., Patel A., Ginsburg S., FitzGerald J. M. Bronchodilator delivery in acute airflow obstruction. A meta-analysis. Arch Intern Med. 1997 Aug 11;157(15):1736–1744. [PubMed] [Google Scholar]
  606. Turner M. O., Patel A., Ginsburg S., FitzGerald J. M. Bronchodilator delivery in acute airflow obstruction. A meta-analysis. Arch Intern Med. 1997 Aug 11;157(15):1736–1744. [PubMed] [Google Scholar]
  607. Ullah M. I., Newman G. B., Saunders K. B. Influence of age on response to ipratropium and salbutamol in asthma. Thorax. 1981 Jul;36(7):523–529. doi: 10.1136/thx.36.7.523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  608. Upham J. W., Holt B. J., Baron-Hay M. J., Yabuhara A., Hales B. J., Thomas W. R., Loh R. K., O'Keeffe P. T., Palmer L., Le Souef P. N. Inhalant allergen-specific T-cell reactivity is detectable in close to 100% of atopic and normal individuals: covert responses are unmasked by serum-free medium. Clin Exp Allergy. 1995 Jul;25(7):634–642. doi: 10.1111/j.1365-2222.1995.tb01111.x. [DOI] [PubMed] [Google Scholar]
  609. Utell M. J., Morrow P. E., Speers D. M., Darling J., Hyde R. W. Airway responses to sulfate and sulfuric acid aerosols in asthmatics. An exposure-response relationship. Am Rev Respir Dis. 1983 Sep;128(3):444–450. doi: 10.1164/arrd.1983.128.3.444. [DOI] [PubMed] [Google Scholar]
  610. VANARSDEL P. P., Jr, SHERMAN W. B. The risk of inducing constitutional reactions in allergic patients. J Allergy. 1957 May;28(3):251–261. doi: 10.1016/0021-8707(57)90130-2. [DOI] [PubMed] [Google Scholar]
  611. Vathenen A. S., Knox A. J., Higgins B. G., Britton J. R., Tattersfield A. E. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet. 1988 Mar 12;1(8585):554–558. doi: 10.1016/s0140-6736(88)91352-9. [DOI] [PubMed] [Google Scholar]
  612. Vollmer W. M., O'Hollaren M., Ettinger K. M., Stibolt T., Wilkins J., Buist A. S., Linton K. L., Osborne M. L. Specialty differences in the management of asthma. A cross-sectional assessment of allergists' patients and generalists' patients in a large HMO. Arch Intern Med. 1997 Jun 9;157(11):1201–1208. [PubMed] [Google Scholar]
  613. Vrugt B., Wilson S., van Velzen E., Bron A., Shute J. K., Holgate S. T., Djukanovic R., Aalbers R. Effects of high dose intravenous immunoglobulin in two severe corticosteroid insensitive asthmatic patients. Thorax. 1997 Jul;52(7):662–664. doi: 10.1136/thx.52.7.662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  614. Waldeck B. Some pharmacodynamic aspects on long-acting beta-adrenoceptor agonists. Gen Pharmacol. 1996 Jun;27(4):575–580. doi: 10.1016/0306-3623(95)02052-7. [DOI] [PubMed] [Google Scholar]
  615. Walshaw M. J., Evans C. C. Allergen avoidance in house dust mite sensitive adult asthma. Q J Med. 1986 Feb;58(226):199–215. [PubMed] [Google Scholar]
  616. Warner J. A., Jones A. C., Miles E. A., Colwell B. M., Warner J. O. Prenatal origins of asthma and allergy. Ciba Found Symp. 1997;206:220–232. doi: 10.1002/9780470515334.ch14. [DOI] [PubMed] [Google Scholar]
  617. Wasserman S. I. A review of some recent clinical studies with nedocromil sodium. J Allergy Clin Immunol. 1993 Jul;92(1 Pt 2):210–215. doi: 10.1016/0091-6749(93)90111-r. [DOI] [PubMed] [Google Scholar]
  618. Wasserman S. I., Furukawa C. T., Henochowicz S. I., Marcoux J. P., Prenner B. M., Findlay S. R., Gross G. N., Hudson L. D., Myers D. J., Steinberg P. Asthma symptoms and airway hyperresponsiveness are lower during treatment with nedocromil sodium than during treatment with regular inhaled albuterol. J Allergy Clin Immunol. 1995 Feb;95(2):541–547. doi: 10.1016/s0091-6749(95)70316-0. [DOI] [PubMed] [Google Scholar]
  619. Wechsler M. E., Garpestad E., Flier S. R., Kocher O., Weiland D. A., Polito A. J., Klinek M. M., Bigby T. D., Wong G. A., Helmers R. A. Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast. JAMA. 1998 Feb 11;279(6):455–457. doi: 10.1001/jama.279.6.455. [DOI] [PubMed] [Google Scholar]
  620. Weiss K. B., Gergen P. J., Hodgson T. A. An economic evaluation of asthma in the United States. N Engl J Med. 1992 Mar 26;326(13):862–866. doi: 10.1056/NEJM199203263261304. [DOI] [PubMed] [Google Scholar]
  621. Westerman D. E., Benatar S. R., Potgieter P. D., Ferguson A. D. Identification of the high-risk asthmatic patient. Experience with 39 patients undergoing ventilation for status asthmaticus. Am J Med. 1979 Apr;66(4):565–572. doi: 10.1016/0002-9343(79)91165-3. [DOI] [PubMed] [Google Scholar]
  622. White P. F. Comparative evaluation of intravenous agents for rapid sequence induction--thiopental, ketamine, and midazolam. Anesthesiology. 1982 Oct;57(4):279–284. doi: 10.1097/00000542-198210000-00005. [DOI] [PubMed] [Google Scholar]
  623. White P. F., Way W. L., Trevor A. J. Ketamine--its pharmacology and therapeutic uses. Anesthesiology. 1982 Feb;56(2):119–136. doi: 10.1097/00000542-198202000-00007. [DOI] [PubMed] [Google Scholar]
  624. White P. T., Pharoah C. A., Anderson H. R., Freeling P. Randomized controlled trial of small group education on the outcome of chronic asthma in general practice. J R Coll Gen Pract. 1989 May;39(322):182–186. [PMC free article] [PubMed] [Google Scholar]
  625. Wildhaber J. H., Devadason S. G., Hayden M. J., Eber E., Summers Q. A., LeSouëf P. N. Aerosol delivery to wheezy infants: a comparison between a nebulizer and two small volume spacers. Pediatr Pulmonol. 1997 Mar;23(3):212–216. doi: 10.1002/(sici)1099-0496(199703)23:3<212::aid-ppul7>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  626. Williams S. J., Winner S. J., Clark T. J. Comparison of inhaled and intravenous terbutaline in acute severe asthma. Thorax. 1981 Aug;36(8):629–631. doi: 10.1136/thx.36.8.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  627. Williams S., Seaton A. Intravenous or inhaled salbutamol in severe acute asthma? Thorax. 1977 Oct;32(5):555–558. doi: 10.1136/thx.32.5.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  628. Williams T. J., Spencer J., Fahey T., Harris L. Timing of discharge from hospital of patients admitted with asthma: a district general hospital experience. J R Coll Physicians Lond. 1994 Jul-Aug;28(4):306–309. [PMC free article] [PubMed] [Google Scholar]
  629. Wilson N. M. The significance of early wheezing. Clin Exp Allergy. 1994 Jun;24(6):522–529. doi: 10.1111/j.1365-2222.1994.tb00949.x. [DOI] [PubMed] [Google Scholar]
  630. Wilson S. R., Scamagas P., German D. F., Hughes G. W., Lulla S., Coss S., Chardon L., Thomas R. G., Starr-Schneidkraut N., Stancavage F. B. A controlled trial of two forms of self-management education for adults with asthma. Am J Med. 1993 Jun;94(6):564–576. doi: 10.1016/0002-9343(93)90206-5. [DOI] [PubMed] [Google Scholar]
  631. Wong C. S., Cooper S., Britton J. R., Tattersfield A. E. Steroid sparing effect of nedocromil sodium in asthmatic patients on high doses of inhaled steroids. Clin Exp Allergy. 1993 May;23(5):370–376. doi: 10.1111/j.1365-2222.1993.tb00341.x. [DOI] [PubMed] [Google Scholar]
  632. Wong C. S., Wahedna I., Pavord I. D., Tattersfield A. E. Effect of regular terbutaline and budesonide on bronchial reactivity to allergen challenge. Am J Respir Crit Care Med. 1994 Nov;150(5 Pt 1):1268–1273. doi: 10.1164/ajrccm.150.5.7952551. [DOI] [PubMed] [Google Scholar]
  633. Wood R. A., Chapman M. D., Adkinson N. F., Jr, Eggleston P. A. The effect of cat removal on allergen content in household-dust samples. J Allergy Clin Immunol. 1989 Apr;83(4):730–734. doi: 10.1016/0091-6749(89)90006-7. [DOI] [PubMed] [Google Scholar]
  634. Woolcock A. J. Steroid resistant asthma: what is the clinical definition? Eur Respir J. 1993 May;6(5):743–747. [PubMed] [Google Scholar]
  635. Woolcock A., Lundback B., Ringdal N., Jacques L. A. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med. 1996 May;153(5):1481–1488. doi: 10.1164/ajrccm.153.5.8630590. [DOI] [PubMed] [Google Scholar]
  636. Woolcock A., Rubinfeld A. R., Seale J. P., Landau L. L., Antic R., Mitchell C., Rea H. H., Zimmerman P. Thoracic society of Australia and New Zealand. Asthma management plan, 1989. Med J Aust. 1989 Dec 4;151(11-12):650–653. [PubMed] [Google Scholar]
  637. Worrall G., Chaulk P., Freake D. The effects of clinical practice guidelines on patient outcomes in primary care: a systematic review. CMAJ. 1997 Jun 15;156(12):1705–1712. [PMC free article] [PubMed] [Google Scholar]
  638. Worth H. Patient education in asthmatic adults. Lung. 1990;168 (Suppl):463–468. doi: 10.1007/BF02718165. [DOI] [PubMed] [Google Scholar]
  639. Worthington J. R., Ahuja J. The value of pulmonary function tests in the management of acute asthma. CMAJ. 1989 Jan 15;140(2):153–156. [PMC free article] [PubMed] [Google Scholar]
  640. Wrenn K., Rodewald L., Lumb E., Slovis C. The use of structured, complaint-specific patient encounter forms in the emergency department. Ann Emerg Med. 1993 May;22(5):805–812. doi: 10.1016/s0196-0644(05)80796-6. [DOI] [PubMed] [Google Scholar]
  641. Wright R. O., Santucci K. A., Jay G. D., Steele D. W. Evaluation of pre- and posttreatment pulse oximetry in acute childhood asthma. Acad Emerg Med. 1997 Feb;4(2):114–117. doi: 10.1111/j.1553-2712.1997.tb03716.x. [DOI] [PubMed] [Google Scholar]
  642. Yamamoto L. G., Wiebe R. A., Anaya C., Chang R. K., Chang M. A., Terada A. M., Bray M. L., Ching C. Y., Kim M. Y., Shinsato E. T. Pulse oximetry and peak flow as indicators of wheezing severity in children and improvement following bronchodilator treatments. Am J Emerg Med. 1992 Nov;10(6):519–524. doi: 10.1016/0735-6757(92)90175-w. [DOI] [PubMed] [Google Scholar]
  643. Yamamoto L. G., Wiebe R. A., Rosen L. M., Ringwood J. W., Uechi C. M., Miller N. C., Beardsly E. S., Toshi A. S., Sugimoto S. P., MacPherson K. A. Oxygen saturation changes during the pediatric emergency department treatment of wheezing. Am J Emerg Med. 1992 Jul;10(4):274–284. doi: 10.1016/0735-6757(92)90002-f. [DOI] [PubMed] [Google Scholar]
  644. Yang H. M., Ma J. Y., Castranova V., Ma J. K. Effects of diesel exhaust particles on the release of interleukin-1 and tumor necrosis factor-alpha from rat alveolar macrophages. Exp Lung Res. 1997 May-Jun;23(3):269–284. doi: 10.3109/01902149709087372. [DOI] [PubMed] [Google Scholar]
  645. Yates D. H., Sussman H. S., Shaw M. J., Barnes P. J., Chung K. F. Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment. Am J Respir Crit Care Med. 1995 Oct;152(4 Pt 1):1170–1174. doi: 10.1164/ajrccm.152.4.7551366. [DOI] [PubMed] [Google Scholar]
  646. Yoon R., McKenzie D. K., Bauman A., Miles D. A. Controlled trial evaluation of an asthma education programme for adults. Thorax. 1993 Nov;48(11):1110–1116. doi: 10.1136/thx.48.11.1110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  647. Youngchaiyud P., Permpikul C., Suthamsmai T., Wong E. A double-blind comparison of inhaled budesonide, long-acting theophylline, and their combination in treatment of nocturnal asthma. Allergy. 1995 Jan;50(1):28–33. doi: 10.1111/j.1398-9995.1995.tb02480.x. [DOI] [PubMed] [Google Scholar]
  648. Zeiger R. S., Heller S. The development and prediction of atopy in high-risk children: follow-up at age seven years in a prospective randomized study of combined maternal and infant food allergen avoidance. J Allergy Clin Immunol. 1995 Jun;95(6):1179–1190. doi: 10.1016/s0091-6749(95)70074-9. [DOI] [PubMed] [Google Scholar]
  649. Ziment I. Alternative therapies for asthma. Curr Opin Pulm Med. 1997 Jan;3(1):61–71. doi: 10.1097/00063198-199701000-00010. [DOI] [PubMed] [Google Scholar]
  650. Zimmerman B., Gold M., Wherrett D., Hanna A. K. Adrenal suppression in two patients with asthma treated with low doses of the inhaled steroid fluticasone propionate. J Allergy Clin Immunol. 1998 Mar;101(3):425–426. doi: 10.1016/S0091-6749(98)70260-X. [DOI] [PubMed] [Google Scholar]
  651. Zwillich C. W., Neagley S. R., Cicutto L., White D. P., Martin R. J. Nocturnal asthma therapy. Inhaled bitolterol versus sustained-release theophylline. Am Rev Respir Dis. 1989 Feb;139(2):470–474. doi: 10.1164/ajrccm/139.2.470. [DOI] [PubMed] [Google Scholar]
  652. van Noord J. A., Smeets J. J., Raaijmakers J. A., Bommer A. M., Maesen F. P. Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action. Eur Respir J. 1996 Aug;9(8):1684–1688. doi: 10.1183/09031936.96.09081684. [DOI] [PubMed] [Google Scholar]
  653. van Schayck C. P., Graafsma S. J., Visch M. B., Dompeling E., van Weel C., van Herwaarden C. L. Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol. J Allergy Clin Immunol. 1990 Nov;86(5):793–800. doi: 10.1016/s0091-6749(05)80185-x. [DOI] [PubMed] [Google Scholar]
  654. van der Heide S., De Monchy J. G., De Vries K., Dubois A. E., Kauffman H. F. Seasonal differences in airway hyperresponsiveness in asthmatic patients: relationship with allergen exposure and sensitization to house dust mites. Clin Exp Allergy. 1997 Jun;27(6):627–633. doi: 10.1046/j.1365-2222.1997.d01-554.x. [DOI] [PubMed] [Google Scholar]
  655. van der Palen J., Klein J. J., Rovers M. M. Compliance with inhaled medication and self-treatment guidelines following a self-management programme in adult asthmatics. Eur Respir J. 1997 Mar;10(3):652–657. [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES